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ABSTRACT
This thesis discusses two problems of increasing economical importance in modem pig production 
which are excess death loss and excess numbers of substandard pigs, that is, pigs which do not reach 
the minimal weight to assure optimal revenue. In one farm system studied, the proportion of weaned 
pigs sold at full value was 21.4 percentage points below a target value of 94.0%. A review of the 
literature proposes many potential causes for increased mortality, but relatively little published 
literature on substandard pigs is available.
In a retrospective analysis of farm production data, the interaction quarter*year was associated with 
mortality rate and substandard rate (p < 0. 01), and sex was significantly related to mortality rate 
(p<0.01). In a prospective trial of 12 cohorts, the administration of an antibiotic with a bacteriostatic 
effect on M hyopneumoniae was associated with a 12.7% substandard rate, compared with at 26.4% 
substandard rate for cohorts offered feeds with antibiotics not labeled for respiratory diseases 
(p<0.01). It was concluded the respiratory diseases and M. hyopneumoniae infection in particular 
may have played a role in the increased mortality and substandard rates for this farm system.
The scientific literature revealed little data linking M. hyopneumoniae to elevated mortality' and 
substandard pigs. To more precisely define this apparent relationship, a prospective analysis of 48 
cohorts of growing pigs was conducted, each cohort containing approximately 1,200 pigs. Halt of 
the cohorts were vaccinated against M. hyopneumoniae and the study was blocked on farm site, sex, 
and time blocks. Cohorts vaccinated against M. hyopneumoniae grew 42 g/pig/day faster and had
15.2 fewer deaths per 1,000 pigs when compared with unvaccinated cohorts. The time to Porcine 
Reproductive and Respiratory Syndrome virus intection was directlv associated with changes in
mortality rate and the proportion of pigs culled for poor performance, but did not appear to modify 
the protective eflects of M. hyopneumoniae vaccination.
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This work is dedicated to the memory of my father, Dr. Antonio Moreau.
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DEFINITIONS
Acclimatization
Age Segregated 
production
Closed herd
Closeout report
Cull pigs 
Finisher
Multisite system
Nursery
Prime weight 
range
Pyramid
Site
Period when the immune system of replacement animals is exposed through 
vaccination or natural exposure to pathogens with which animals are likely to 
come in contact after introduction in the breeding herd
Segregation of pigs on the basis of age groups. This practice is associated with 
improved growth performance. The degree of improvement is in part related to 
the degree of isolation and so is increasing as the segregation occurs at the level 
of the pen, room, bam and site.
Genetic improvement is brought to parent animal solely through artificial 
insemination. No females are directly introduced into breeding herd
A report produced after all pigs in a cohort are sold, which lists the descriptive 
statistics of the cohort such as average daily gain, feed efficiency, and cost per kg 
of gain, operating cost and slaughter revenue of cohorts of pigs raised in a 
finishing bam from 25 kg (70 days of age) to 125 kg (185 days of age).
Any live pig removed from the herd due to substandard pigs performance, 
behavior conformation, age or disease
Post-weaning growth phase in modem pig production is subdivided into a 
nursery and a finishing phase. Pigs are considered in their finishing phase from 
eight to ten weeks of age until 25 to 30 weeks of age.
Any system where pigs are weaned at a location separated from the sows. It is 
more frequently applied to production systems where pigs of one age group (one 
week) occupy an entire nursery or finishing site.
Post-weaning growth phase in modern pig production is subdivided into a 
nursery and a finishing phase. Pigs are considered typically in their nursery 
phase at two to three weeks of age (age of weaning) to eight to ten weeks of age.
Minimum and maximum hot carcass weight for which slaughter plant pay the 
carcass above the market price. The weight range vary by slaughter plant and 
was between 99.8 and 122.5 kg for the present slaughter system
The group of breeding herds supplying pigs to the same group of nursery and 
finisher site
Location of a farm or a group of bams
Standard pigs 
Substandard pigs 
Unthrifty pigs
Pigs sold within its target market weight range that is not substantially 
discounted from the base price.
Pigs sold outside of its target market weight range and/or substantially 
discounted from the price received for other pigs in its contemporary group
Pigs of poor body condition, substantially smaller than its pen mates, showing 
signs of sickness such as lameness, severe tail biting, dyspnea, paleness
xiv
FOREWORD
The author at the time of writing was Director of Health Management for a commercial swine 
enterprise, slaughtering one million finisher pigs per year, using age segregated production system. 
The projects included in this thesis grew out of the experiences as the health manager for the system. 
The farm system had a history’ of death loss above the enterprise goal. It offered access to complete 
and reliable production data, and it used key production practices similar to many recently 
constructed farms (Harris, 2000). Because this system is central to much of the material described in 
this thesis manuscript, a brief description of the system follows.
The breeding stock sites
One production section of this system had two breeding herd farms of 5,400 and 7.200 sows, 
supplying weekly 5,200 weaned pigs to a multisite nursery and finisher system. For better health 
control, replacement females introduced into the breeding herds were reared in a closed herd 
multiplier and were prepared through a strict program of acclimatization, using vaccines and 
exposure to live adult females, followed by a quarantine period of a minimum of 80 days prior to 
introduction into one of the two breeding herds.
The nurseries and the weaned pigs
Within a 10 miles radius, there were four nursery sites with a designed capacity of 10,400 piglets at 
each site. Nursery sites had two bams, each with four rooms, holding one week of combined 
production from the two breeding herds. Waste was stored under the slotted plastic flooring and 
flushed weekly to outside holding pools. Air was exchanged by fans controlled by thermostats, with 
minimum ventilation rates defined for each week ot age. Supplemental heat was provided to
maintain minimum temperature targets. Additional details of the facility design can be found in 
appendix A, at the end of the thesis.
Targets for the weekly number of females mated were adjusted seasonally to provide a consistent 
number of weaned pigs. Target quality standards for weaned pigs included the age (13 to 21 days) 
and the minimum individual weight of (3.6 kg judged visually). These standards were relaxed from 
December through April farrowing, when the number of pigs bom decreased because of the seasonal 
infertility. Pigs were separated into sex segregated bam and were allocated to pens based weight to 
increase the uniformity of pigs within pens.
The finisher sites and the finisher pigs
At 10 weeks of age, pigs from nursery rooms w'ere transferred integrally to finishing bams. These 
barns were designed to hold approximately 1,200 pigs per bam. and provide 0.62 m2 floor space per 
pig. Flooring w'as slotted, with 2.5 cm slot betw-een each 6 cm wide slat of concrete, placed over a 
manure pit that was flushed every 3 to 4 days to remove manure from the bam to a lagoon. 
Ventilation was thermostatically controlled using fans placed along one short wall on the east side of 
the finishing barn. At low ventilation rates most air wras introduced by a series of air diffusers, and 
at high rates air was introduced by an opening in the wall opposite to the fans. This provided a wind 
tunnel effect at the highest ventilation rate to aid in pig cooling. At placement into finishing bams, 
pigs were resorted into pens to provide more uniformity of weight within pens. At placement, four 
pens were left empty for management of sick pigs. Pigs showing signs of sickness such as lameness, 
rapid loss of body condition or labored breathing were isolated into these pens.
It is pertinent to highlight that the farm is representative of large Midwestern segregated production 
systems, similar in key respects to many recently constructed farms (Harris, 2000).
1 LITERATURE REVIEW OF RISK FACTORS FOR MORTALITY IN PIGS BETWEEN 
10 AND 26 WEEKS OF AGE
In commercial slaughter pig production, many factors contribute to excess mortality. Risk for dying 
appear to increase as the pig gets older. In an observational study, 26% of deaths occurred in pigs 
between the ages of 8 and 15 weeks and 55% of the total mortality occurred in pigs between 16 and 
24 weeks of age (Jones, 1969). Analysis of finishing mortality produced by one three site 
production system between January' 1996 and January' 2000 (146 observations) showed that weekly 
mortality for pigs between 19 and 29 weeks of age is 4.92 death per 1,000 pigs weeks, which is 
significantly different (< 0.001) from the mortality rate of pigs betw een 9 and 19 weeks of age (2.16 
death / 1,000 pigs week) (Maes et al., 2001).
A tendency for mortality to peak in cohorts of pigs placed during the summer has been reported 
(Maes et al., 2001). Although statistical testing was not applied (Maes et al., 2001).
Gastric ulcer, here defined as a perforated ulcer or a non perforated ulcer with a large quantity of 
blood present in the stomach content is reported as an apparent cause of death in 14% (Straw et al., 
1983) and 29.5% (Pallares et al., 2000) of pigs found dead in the two observational studies 
conducted in the summer on cohorts of segregated pigs. Gastric ulcers were more likely to be found 
in pigs showing pneumonic lesions, suggesting that mycoplasmal pneumonia may increase mortality 
through gastric ulcers (Doster, 2000). Other factors thought to contribute to gastric ulcer 
development in swine include feed particle size (Hedde et al., 1985), sex, high environmental 
temperature, moldy feed, pneumonia, stress, reduced feed intake, and lean genotype (Straw et al., 
1994). Pelleted and mean particle size finer than 578 j.im (Ayles et al., 1996) or finer than 369 jun
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(Regina et al., 1999) are risk factors for gastric ulcers. Finally, ground feed is hypothesized to cause 
gastric ulcers through on ammonia level and the destruction of a pH gradient that in normal stomach 
physiology decreases from the cardiac to the fundus region (Regina et al., 1999).
In two observational studies, pneumonia was considered the cause of death in 20% (Jones, 1969) and 
34% (Pay, 1970) of pigs found dead. Although it rarely occurs alone in commercial operations, 
uncomplicated M. hyopneumoniae by itself is a disease of high morbidity and low mortality. 
Mycoplasmal pneumonia complicated by other viral or bacterial agents, on the other hand, has been 
indirectly associated with elevated mortality (Straw et al., 1999).
M  hyopneumoniae vaccine may reduce death loss rate (Schwartz and Hoover, 1998; Pommier et al., 
2000; Yeske et al., 2000; Lawton et al., 2000; Van Nes et al., 2000; Maes et al., 1999; Pallares et al., 
2000; Maes et al., 1998). Three of eight vaccine studies reporting mortality rate showed a 
significant effect of M. hyopneumoniae vaccine on finishing mortality rate (Pallares et al., 
2000;Yeske et al., 20001 Schwartz and Hoover, 1998). In these three studies, the relative effect size 
of M. hyopneumoniae vaccine relative to control pigs not vaccinated varied from (1.3% to 100%). 
Table 1.1 presents the degree of change in mean mortality7 rates between control (not vaccinated) and 
vaccinated pigs.
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Table 1.1 Design characteristics and results of studies testing the effect of M. hyopneumoniae 
vaccine in growing pigs.
Reference N* ' Challenge
model
Duration 
(weeks of 
age)
Vaccination 
time (weeks 
of age)
% change compared to control negative
ADG FE PNPR* PNSCJ DEAD
Studies using cohorts o f age segregated pigs
Yeske et ai.. 2000 384 Natural 0 to SLTR' 8 5,6 9.2* 35.0*
8 and 11 4.1* 9.2* 46.2*
Pommier et al.. 2000 12 Natural SLTR 1 and 3 4.8^" 20* 24.0*
Van Nes et al., 2000 24 Natural 0 to SLTR 1 and 3 4.0s 4.1* 14.8“
Pal lares et al.. 2000 16 Natural 8 to 23 1 and 3 1.73“ 3.27* 60.7*
Maes et al., 1999 14 Natural 1 and 3 3.6* 2.41* 48s 65.0* 5.75“
All treatment in same Airspace. Study 
unit
Is Individual
Pig
Lawton et al.. 2000 8000 Natural 10 to SLTR 1 and 3 7.5* 4.9“ 62.2 35.8“
Diekman et al.. 1999 216 Seeder naturally 
infected
0 to 28 1 and 4 2.56"* 0.97“ 23.52“ o»
Vraa Andersen et al., 1992 1500 Natural 3 to 20 1 and 3 0.99s 50.83* 28.0*
3 and 5 4.10s 47.34s 32.45*
Maes et al., 1998 2060 Natural 11 to 28 I and 4 4 2* 1.3“
Schwartz et al., 1998 39 Seeder
inoculated Intra 
tracheally
3 and 5 5.69s 5.64s 59.88* 100* 100*
3 and 5 1.90"5 1.33“ 51.68s 67.5* 73.7“
Bilic et al., 1996 140 Natural 10 to 25 12 and 14 7 12.37 77.44 83.64
Miller and Schuelter. 1998 192 Natural 1 to 15 3 and 6 9.5* 2.9“ 63“
Charlier et al„ 1994 550 Natural 4 to 24 I and 4 ' 2.10 63.7 40.7
Lium et al., 1994 312 Natural 3 to 25 2 and 5 0.4"* 74.1* 51.4s...
2 and 5 I 4ns 35.2* 16.13*
Pommier et al., 2000 1287 Natural 10 to SLTR 10 2.22* 3.0“ 93* 24.38“ 3.5“
Paterson et al.. 2000 1904 Natural SLTR 100% group 
vaccinated
63.5* 45.9*
50% group 
vaccinated
52.8s 12.7“
Munoz et al., 1996 12826 Natural 1 and 3 ' 7.6 3.0 30.0 61.9
Dohoo and Montgomery. 1996 12 Natural 3 and 6 47.82*
All treatment in same Airspace Study 
unit is a
Pen
Scheidt et al., 1994 18 Seeder naturally 
infected
1 to 26 1 and 3 7.69s 6.67" 50.0*
6 and 8 7.69* 6.67“ 66.7*
Morrow et al., 1994 16 Natural 3 to 21 3 and 5 Ns
1 and 4 O&t 1.95* 53.21“ 33.3**
rN: total sample size used to estimate effect o f vaccine on ADG;
2 PNPR: pneumonia prevalence
’ PNS: pneumonia score; proportion o f the lung affected by pneumonia
4 SLTR: slaughter
5 S: statistically significant for p < 0.05 
'’NS: statistically not significant for p < 0.05
Statistically tests not applied
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Feed antimicrobials have a favorable significant effect on mortality (Table 2.1). Studies with 
baseline mortality rate of 2.66% (Walter et al., 2000) and 10.4% (Jouglar et al., 1993) in cohorts of 
pigs not medicated reported a relative reduction in mortality of 52.3% and 100%, respectively.
A logistic regression model made from 327 US farrow to finish farms and 60 grower finisher farms 
with more than 300 pigs on site identified certain risk factors for elevated mortality rates. Herds 
with elevated mortality rates reported 1) weaning age younger than 28 days 2) absence of E. coli 
vaccination of the dam 3) single source of the grower finisher farm as factors associated to finishing 
mortality equal or above of 4%. The number of pigs sold to slaughter during the six month of 
observation (herd size) and the type of production system (farrow to finish versus off site growrer 
finisher) did not contribute to elevated (> 4%) mortality rates equal (Losinger et al., 1998). 
Observational studies such as this study are complex to understand due to the large number of 
variables modeled and the subjective interpretation of some of the risk studied. For instance, E. coli 
vaccination of sows may be reflective of the farm husbandry7 level rather than a direct effect on 
finisher mortality, and weaning age below 28 days may be dictated by the need to control disease 
present in the system. This national study supports the multifactorial nature of mortality in finishing 
age pigs.
Studies conducted in modern segregated pig production are needed to quantify and identify the 
relative importance of the factors affecting mortality. Studies measuring the effect size of husbandry 
interventions or therapeutic interventions intended to reduce mortality wrould be valuable.
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2 LITERATURE REVIEW OF SUBSTANDARD PIGS
A substandard pig is defined as a « pig sold outside of its target market weight range and 
substantially discounted from the price received for other pigs in its contemporary cohorts » (NPPC,
1997). Pigs may become substandard due to their low individual rate of gain, due to husbandry 
practices retarding the growth of the individual pig or the average growth of the cohort or due to
diseases slowing growth.
Literature on substandard pigs is sparse because substandard pigs have surfaced as an economically 
significant problem with the recent development of age segregated production systems. Because few 
reference directly describe the problem of substandard pigs, this review is focussed on the related 
topics. The author elected to include in the review 1) low? individual ADG 2) proportion of pigs not 
sold at prime market weight 3) coefficient of variation of individual pigs in a treatment.
Individual pigs may show low daily gain. Some variation in final weight of groups of pigs is 
unavoidable because of the effects of sex and dam. Difference in body composition between 
females and castrated males influence the mean ADG between the two sexes (English et al., 1988). 
For instance, a mean growth rate of 796 g/d for pigs between 10 and 26 weeks of age and a 
difference between castrated male and female of 3% will result in 2.6 kg mean difference between 
the two sexes. Roker individually weighed 1,000 pigs at birth, weaning and at market, where the 
target market weight was between 83 and 116kg (1996). In a multivariate analysis, she reviewed the 
effect of birth weight, wean weight, sex and dam effect on growth rate. Roker concluded that ADG 
from weaning to slaughter was significantly affected by slaughter age, dam, birth weight, sex, wean 
weight and wean age (R2 = 0.88) (1996).
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Some husbandry practices may retard the growth of the individual pig or the average growth of the 
cohort. Practices intended to reduce weight variation such as fostering (Straw, 1997) or sorting at 
placement into the finisher (Quinn et al., 2001) do not significantly reduce the weight variation 
within a group of pigs. In a control study, Straw measured the individual weight at weaning (19 
days or age) and the standard deviation of individual weight based on the fostering method. The 
fostering methods compared were continuously fostered from birth to weaning to obtain litter of 
uniform size pigs and early foster from birth to three days old only. Continuously fostering litters 
resulted in significantly heavier mean weight (p < 0.008) but significantly larger standard deviation 
of individual weight (<0.01) (Straw, 1997). In a randomized complete block design using eight 
replicates (pens of 12 pigs) per treatment (heavy, medium or light pig groups and pig groups not 
sorted according to body size), Quinn demonstrated that groups of pigs with uniform body size at 
placement (14 weeks of age, 30 to 37 kg) show the same standard deviation in final weight (27 
weeks of age 7.4 to 9.3 kg) than pigs groups not sorted according to body size at placement (Quinn 
et al., 2001). Heavier pigs at weaning maintain their weaning weight advantage through to market 
w'eight (Mahan and Lepin, 1991; Tokach et al., 1992, Tokach et al., 1998), thus the difference 
between the lightest and the heaviest pigs increase as the pigs aged (Moore, 1993).
Mycoplasma vaccination can increase the proportion of pigs sold at prime market weight. Paterson 
demonstrated that individual growth rate was superior in pigs vaccinated for M. hyopneumoniae 
relative to un-vaccinated pigs raised in the same airspace (2000). Three segregated pig cohorts 
either fully, partially (50%) or not vaccinated for M. hyopneumoniae resulted in significantly 
different (p < 0.05) proportion of pigs reaching 100 kg by 22 weeks of age, (Paterson et al., 2000).
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Antimicrobials have been demonstrated to reduce substandard pigs produced in a modem 
commercial production system raising cohorts of pigs affected with M. hyopneumoniae and PRRSv 
(Table 2.1). Chlortetracycline feed continuously (Gourley and Wolff, 1997; Deen et al., 1999) or in 
pulse (Gourley, 1998) was reported to reduce the proportion of substandard pigs. In the first study, 
the estimate of substandard pigs was the proportion of pigs sold under the prime market weight, and 
was numerically lower among treated cohorts (Gourley and Wolff, 1997). In the second study, the 
estimate of substandard pigs was the odds ratio of having slowr growing pigs (slow growing pigs = 
ADG < 771 g/d from 24 to 121 kg) and was found significantly (p = 0.013) lower relative to non­
medicated controls (Deen et al., 1999). In the third study, the estimate of substandard pigs was the 
coefficient of variation for 24 pens of 24 pigs weighed individually (eight pens per treatment). The 
feed antimicrobial chlortetracycline fed continuously or in pulse significantly reduced the coefficient 
of variation (p = 0.021) (Gourley, 1998). These studies indirectly support the idea that diseases may 
increase substandard pigs produced in a cohort, since an important effect of antibiotics is to suppress 
bacterial diseases.
The economic consequences of marketing underweight pigs can be substantial (Miller et al., 2001). 
Certain causes of substandard pigs, such as female or genotype are beyond the control of the 
herdsman. However, other factors, under the control of the herdsman may improve the proportion of 
substandard pigs produced by a cohort. Further work is needed to identify factors which the 
herdsman can manipulate.
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Table 2.1 The percentage change in growth measures associated with feed antimicrobial 
administration in growing pigs
R eference S tudy  D esign tre a tm e n t Prop
M R K T '
Prop cull o r 
dead3
Prop dead * .....C V  o f  final
w t 4
A D G
5
F E '
1 Studies conducted  using  the airspace  u  the un it o f  analysis (bam )
K avanagh, 1994 B efo re  and  after in  a 
F arrow  to  finish Farm
A ug to  Nov
O x y te tra cy d in e  300  / tiam ulin 
30
5* 3
Apr to July
C h k x e tra cy d in e  300 /  tiam ulin 
30
-15 46
11 Studies conducted  using  pens w ith in  airspace  as the unit o f  analysts
Feed an tim icrobials given  con tin u o u sly
Pott and Edw ards. 1990 T iam ulin 40 from  w ean to  
SLTR
1 7 * 8 3 0 0 9 1
Burch et a i . 1986 R epeated  2x on  sam e 
P 'iP
C hlortetracychne 30 100 6  10 1 33
C h b rte tra c y d in e  300 / 
T iam ulin 100
6 25 Z 5 9 0  02
Jouglar et a f . 1993 O x y te tra cy d in e  300 /  
T iam ulin 100
0 6 3 100* 3 3 3 4 78
V anB uren et al . 2001 Lincom ycin 5 0 0 9 58 2 0 1
Deen el a l . 1999 C hlortetracvclm e 90 24 8* 1 97 2 3 3
C hlonetracycline 90  /  B aciferm 1 7 6 1 48 3 33
T ylan 20 IS 1
B acitracin M ethylene 
D isahcvlate 30
8 8
Feed an tim icrobials given  in pulses
W alter et a l . 2000 12 to  23 w k o f  age T iam ulin 38 5 /  
C hlonetracycline 22 mgAcg
89 46* 9 6 5 3 61
i f  to  23 wk o f  age T iam ulin 38 5 /
C hlone tracycline  22 m g 'k g  and 
110 C hlone tracycline  betw een 
pulses
63 22* 8 95 3 93
(jou rley , 1998 C hlone tracvclm e 9 0 ' 24 8* 3 59 1 47
C hlone tracycline 90 10.57 1.24 1 76
Feed inclusion rate is in PPM unless otherwise indicated; Wk: week; (-) a negative sign indicates an unfavorable effect; 
(*) indicates significant difference with P-value < 0.05; FE: feed efficiency is calculated as the weight o f feed delivered 
divided by weight gained.
All numbers are in percent change relative to control negative 
1 Prop. MRK.T: proportion o f pigs marketed.
: Prop, cull or dead: proportion o f pigs dead and culled
3 Prop. Dead: proportion o f dead pig
4CV final weight: coefficient o f variation o f live weight at slaughter 
5ADG: average daily gain
6 FE: feed efficiency
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3 INVESTIGATION CONDUCTED TO DEFINE FACTORS ASSOCIATED WITH 
MORTALITY AND SUBSTANDARD PIGS IN THE SEGREGATED PRODUCTION 
FARM UNDER STUDY. 
3.1 Abstract
Between June 1996 and December 2000, the author investigated the causes of elevated mortality and 
the causes of elevated proportion of pigs sold outside the optimal weight range. The system studied, 
weaned approximately 5,000 pigs weekly into four separate airspace. Data collected included the 
number of dead pigs per cohort of pigs produced, the number of substandard pigs produced in paired 
same sex cohorts raised during the same week, visual description of reasons for death, lesions found 
during necropsy of selected dead pigs, antibodies detected to M. hyopneumoniae and Porcine 
Reproductive and Respirator)' Syndrome virus (PRRSv), prevalence of pneumonic lesions observed 
on slaughter age pigs, and the vaccination and feed antimicrobial program associated with each 
cohort of pig produced. The significance of the effects of sex, season, and tilmicosin were analyzed 
by analysis of variance methods. All other effects were described but not statistically tested, as the 
study design did not include complete concurrent controls.
Sex and season were found to have a significant effect on mortality. Gilt mortality rate was 30% 
lower than castrated males, and pigs sold between July and December showed a higher death loss 
than pigs sold between January and June. The mean mortality rate for cohorts of nursery age pigs 
receiving tilmicosin was 8.1% while the mean mortality rate for those not receiving tilmicosin was 
9.5%. This relative difference of 14.7% lower mortality was not significantly different. The mean 
substandard rate for cohorts of pigs receiving tilmicosin was 12.7% wrhile the mean substandard rate
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for cohorts of pigs not receiving tilmicosin was 26.4%. This relative difference of 51.9% was 
significantly affected by the treatment (p < 0.05).
Other observations, although not subject to statistical testing, suggested a role of respiratory disease 
on mortality. Cohorts of pigs vaccinated for M. hyopneumoniae tended to have a lower rate of 
mortality than cohorts of pigs not vaccinated. Cohorts of pigs fed with antimicrobials that target 
respiratory pathogens tended to have a lower rate of mortality that cohorts of pigs fed with 
antimicrobials that target intestinal pathogens. The mortality rate for pigs (10 weeks old) placed in 
empty finisher sites was numerically lower than the mortality rate of pigs placed on sites w-here older 
pigs were still present (24 weeks old).
3.2 Introduction
The objective of this study was to identify risk factors for mortality or substandard pigs in the 
segregated production farm under study. The risk factors discussed were selected from risk factors 
identified in the literature review. In part I, the health program and the aspects of husbandry 
possibly related to increased mortality and substandard rate are described in the context of this 
specific segregated pig production system. In part II, diseases diagnosed in the present finishing 
farm system are presented. In part III, the importance of factors associated with finishing mortality 
and substandard pigs identified in the literature are described.
3.3 Part I: variables potentially affecting the health status of pigs placed in the finisher
The variables potentially affecting the health status of pigs placed in the finisher, considered in this 
study are: 1) the gilt acclimatization program 2) the breeding herd vaccination program 3) female 
replacement rate 4) management of pigs at weaning 5) management of finishing pigs at placement 6) 
management of sick finishing pigs 7) diets provided to pigs while in the finisher.
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3.3.1 Gilt acclimatization program, breeding herd vaccination program, and female replacement 
rate
Females introduced into the implied breeding herds were reared in a closed herd multiplier and were 
prepared through a strict program of exposure to pathogens, present on the recipient farm 
(acclimatization). The acclimatization program included the use of vaccines and exposure to live 
animals, followed by a quarantine period of a minimum of 80 days prior to their entry into the 
breeding herd. Vaccines given to females included Porcine Reproductive and Respiratory Syndrome 
virus (PRRSv), parvovirus, Leptospirosis spp, E. coli, M. hyopneumoniae, and swine influenza 
subtypes HiN|. During the study period (June 1996 to December 2000), the annual female 
replacement rate ranged between 63.6% and 80.4%, with a median herd replacement rate of 70.4%. 
These female replacement rates were higher than a national standard (40%) (Kirkwood and Thacker, 
1992). High replacement rate was expected because the farms were populated in 1995 and 1997 and 
so needed adjustment to their parity structure. Overall the health control program for replacement 
females and the breeding herd vaccination program were designed to prevent diseases from infecting 
the finishing pigs. Although high replacement rate was expected, the reader should keep in mind 
that this high proportion of gilt in the breeding herds may interfere with the overall immunity level 
of weaned piglets, as gilts have a lower level of antibodies than mature females (Klobasa and Butler, 
1987). This potentially lower immunity level in weaned piglets could have an impact on the finisher 
mortality and substandard pig rate.
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3.3.2 Management o f  pigs at weaning
Weaned pigs included in this study were selected on the basis of two criteria: the weaning age of 13 
to 21 days and the individual minimum weaning weight of 3.6 kg, judged visually. The 
implementation of selection criteria was relaxed from December through April, when the number of 
pigs born decreased because of seasonal infertility (Love et al., 1993). The number of pigs weaned 
per week varied, although mating targets were adjusted monthly to compensate for the decreased 
farrowing rate associated with the seasonal infertility (Figure 3.1). Increased variation in weaning 
age and weaning weight in the fall may affect the finisher mortality or substandard pig rate through 
the production of light pigs at the end of the nursery phase (Moore, 1995).
Figure 3.1: Weekly number of weaned pigs entering the nursery rooms
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Plus signs represent the weekly number o f pigs weaned. The dotted line represents the rolling average for 8 weeks.
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3.3.3 Management ofpigs at placement into the finisher and management o f  sick finishing pigs
At placement, pigs were sorted into pens to provide more uniformity of weight within pens. At the 
time of pig entry into the finishing bams, four pens were left empty for management of sick pigs. 
Pigs showing signs of sickness such as lameness, rapid loss of body condition or labored breathing 
were removed daily and placed into one of these four pens. If an infectious process was suspected, 
these pigs were injected either with lincomycin for lameness, or penicillin for all others infectious 
diseases. At 18 and at 22 weeks of age, unthrifty pigs not expected to survive and to be sold as 
standard pigs were removed for immediate sale. These sick pigs were sold as substandard pigs and 
so accounted as part of the substandard pig rate. Outside of these two points in time (18 and 22 
weeks of age), unthrifty pigs were euthanized and were accounted as dead pig.
3.3.4 Diets and feed  presentation provided to pigs while in the finisher
Finisher diets were customized for sex and weight of the pigs and designed according to nutritional 
guidelines of the genetic supplier (anonymous, 1999), which exceeded NRC requirements (NRC,
1998). The diets were predominantly based on corn and soybean meal, wheat middlings’ and animal 
fat. The energy density and the lysine level supplied were adjusted during the summer months (June 
to September). The diets, described in Table 3.1, w^ ere not suspected to cause an increase in the 
number of substandard pigs because it was designed in accordance to NRC requirements. This 
statement was supported by ADG of 0.77kg/day, which is equal to the 75th percentile of the national 
average (PigCHAMP, 2000).
1 1 Animal Feeding and Nutrition, 4th e (Marshal Jurgens, c 1978) lists NRC names o f "Wheat, flour by-prod, f-sift, mx 4 
br, Wheat red dog, mx 4 fbr (AAFCO), Middlings, mx 4.5 fbr (CEA)"
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Table 3.1 phase feeding program with composition of diets 1 provided to finisher pigs and expected 
weight change
Feed ration Feed allocated per pig 
(kg o f feed)
Energy density 
(kcal)
Lysine level Expected weight 
change o f pig
castrated Female 
male
diet fed between diet fed between 
October and May June and 
September
diet fed between 
October and May
diet fed between 
June and 
September
initial weight 
(k g )^  final 
weight (kg)
First ration 49.9 47.6 1530 1560 1.05 1.20 22.7 40.8
Second ration 54.4 52.2 1530 1560 0.98 1.05 40.8 63.5
Third ration 59.0 56.7 1500 1530 0.90 0.98 63.5 86.2
Fourth ration 63.5 61.2 1500 1530 0.82 0.90 86.2 108.9
Fifth ration 22.7 22.7 1500 1530 0.70 0.80 108.9 136.1
Other amino acids were balanced in proportion to the lysine according recommendations o f the genetic supplier 
(Anonymous, 1996). For vitamins and minerals, diets fed met or exceeded NRC values. Fiber was as high as 6% in the 
non-summer diets, but was held at a maximum of 3% in the summer. Diet was com/soy/weath middlings'/fat based 
pelleted diet with 12.5% to 13.5% moisture.
The feed form (mill or pelleted) was not suspected to affect the mortality rate nor the substandard 
pig rate. In February 2000, the company began to use a different feed mill for the production of its 
finishing diet designed for pigs between 23 kg and 41 kg. The new feed mill ground com with a 
roller mill rather than a hammer mill and provided feed in a meal form rather than a pelleted form.
Most diets were ground with a hammer mill and pelleted, providing an average grind size of 850 
microns with the distribution of 56.37%, 7.73%, 6.47%, 6.20%, 4.03%, 9.20% and 9.27% of particle 
size fitting in the respective pan size > 850, 850 -710, 710 -  590, 590 -  420, 420 -297, 297 -  150, < 
150 fie (ASAE, 1983).
Stomach ulcers were observed in 40% of 80 pigs necropsied. Feed particule size less than 578 jim 
has been associated with stomach ulcer occurrence (Ayles et al., 1996). To investigate the
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possibility that small particule size was causing increased ulcer-induced-mortalities, meal feed was 
substituted for pelleted feed for eight weeks. The mean mortality rate for eight weeks before and 
eight weeks after the use of feed in a meal form was 4.58% and 6.37% respectively. The mean 
substandard pig rate was 5.85 and 6.82% for cohorts of pigs fed only pelleted feed and cohorts of 
pigs receiving meal feed from 23 to 41 kg, respectively. These apparent increases in mortality rate 
and substandard pig rate among pigs given feed with an expected lower proportion of fine particule 
size cannot necessarily be attributed to feed particule size and pelleting alone, as the change in 
particle size occurred concurrently with the change in feed antimicrobials. Further, cohorts 
receiving the coarser, meal feed were not vaccinated for M. hyopneumoniae and some cohorts were 
placed in the finishing sites where 25 weeks old pig were present. The cohorts receiving pellets 
were vaccinated for A/. hyopneumoniae and were not all placed on sites with older pigs present 
Thus, it was not possible to differentiate between the effects of fineness of grind, pelleting, 
vaccination, and strict age segregation.
3.4 Part II: description of clinical signs, lesions and disease prevalence for three main 
respiratory’ diseases
3.4.1 Clinical signs
Five principle clinical signs were observed among finishing pigs during five month observation 
period. The clinical examination were conducted weekly by a technician trained by the author.
1) Leg stiffness or leg inflammation was most commonly observed during the first four weeks post 
placement into the finisher (10 to 14 weeks of age). This problem was caused either by trauma 
or infection. Individual treatment with injectable lincomycin resolved the lameness in
1 Animal Feeding and Nutrition, 4th e (Marshal Jurgens, c 1978) lists NRC names o f  "Wheat, flour by-prod, f-sift, mx 4 
br, Wheat red dog, mx 4 fbr (AAFCO), Middlings, mx 4.5 fbr (CEA)"
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approximately three-fourths of the pigs affected. Those not responding to treatment commonly 
lost body condition and were removed from the cohorts.
2) Polypnea and dyspnea was observed in 5% to 10% of the pigs, beginning at approximately 
fourteen to eighteen weeks of age.
3) Cough followed a course that was somewhat predictable. Respiratory signs, characterized by dry' 
cough heard early in the morning commonly became noticeable starting at fifteen to twenty 
weeks of age. The cough index, measured as the number of coughs in two pens of pigs for three 
minutes (Bahnson, 1995), varied between zero and seven cough incident per three minutes 
period observed between fifteen and twenty weeks of age.
4) Conjunctivitis was commonly seen at about 16 to 26 weeks of age, affecting over 50% of the 
pigs in a finishing bam.
5) Pale pigs were observed beginning at approximately 16 weeks of age in approximately 30% of 
the pigs. Pale pigs often lost condition and died or were euthanized within 48 hours.
3.4.2 Apparent causes o f  death and lesions observed in pigs
Between June 1999 and October 1999, the author examined 2,725 out of 3,626 dead pigs from 48 
finisher barns. Of these, 86% were found dead and 16% were euthanized. Pigs most commonly 
died with the following lesions/signs, observed by the herdsman: 1) pale pigs 2) cachecia 3) 
dyspnea 4) tail bite 5) rectal stricture 6) umbilical hernia. Table 3.2 presents these lesions/signs 
observed during the monthly visits.
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Table 3.2 Lesions/signs observed among 2,725 pigs found dead or moribund.
Appearance o f 2 725 dead pigs
Prevalence (%)
Pale 41.7
Unknown 26.8
Unthrifty 16.6
Inflamed Leg 7.4
CNS1 2.5
Tail bite 2.1
Thumping 1.8
Other 1.1
Total 100
A pig may show more than one lesion or sign. In the 48 finishing cohorts studied between June 1999 and October 2000, 
3,626 pigs were found dead or moribund but only 2,725 were observed by the author.
1 CNS: central nervous system signs were observed on live pigs prior to dying.
Of the 2,725 pigs observed, the author conducted necropsy on a subset of 97 pigs (Table 3.3). These 
necropsies were conducted among a convenience subset of all dead pigs present on the day of 
monthly herd health visits. When more than one pig was found dead, pigs showing the least post 
mortem lesions were selected for evaluation. Table 3.3 presents the lesions observed during these 
necropsies.
Table 3.3 Cause of death based on gross necropsy found in the finishing stage pig in a farm system
Lesions Number of  
pigs with 
lesions
Stomach ulcer with blood loss 39
Pneumonia 1 5
Pleuritis 27
Inflamed joint 27
Hemorragic proliferative enteropathy 26
Splenomegalia 20
Pericarditis 18
Miliary abscess on the lung 11
Peritonitis 8
A pig could have multiple conditions.
97 examined pigs found dead during periodic visits conducted between June 1999 and October 2000 
1 The average pneumonia score for these 97 lungs examined was 36.3%.
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3.4.3 Prevalence o f  pneumonia lesions observed at slaughter
Between March 1997 and January 2001, the presence or absence of mycoplasmal pneumonia 
observed at slaughter was assessed monthly on four groups of thirty castrated males from four 
different finishing site (Table 3.4).
Table 3.4 Prevalence of grossly observed pneumonic lesions of 26 week-old pigs
N Median Min Max
1997 14 0.3599 0.0345 0.7692
1998 26 0.3274 0.0000 0.6296
1999 21 0.2800 0.0000 1.0000
2000 17 0.2692 0.0313 0.5526
The examination were done by palpation on the slaughter line 
N: number o f cohorts of pigs observed
3.4.4 Pathogens identified from mortalities
Respiratory pathogens including Salmonella group B, PRRSv, M. hyopneumoniae, S. suis, A. suis,
H. parasuis, Porcine Respiratory Coronavirus (PRCV). Porcine Circovirus type II (PCV II) and non 
toxigenic Pasteurella multocida were identified from dead pig through histology, microbiology or 
virology examinations.
3.4.5 Seroprevalence for M. hyopneumoniae, swine influenza HjNi, PRRSv, in pigs between 3 and 
26 weeks o f  age
Between March 1999 and June 1999 serum samples were collected every other w'eek from twenty 
nursery or finisher pigs at each site until the cohorts of pigs were transferred to a finisher bam or 
were slaughtered. Sera were tested for antibody to M hyopneumoniae, swine influenza subtype 
H|N, and PRRSv. In a second survey conducted between June 1999 and December 1999, sera were
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collected from twenty pigs in each of twelve cohorts of pigs at 30, 60, 90, 120 and 150 days of age. 
The sera were tested for the presence of PRRSv and M hyopneumoniae antibodies (Table 3.5).
Cohorts of pigs had detectable antibodies to PRRSv at approximately 50 days of age. The average 
prevalence for M. hyopneumoniae antibody was 32.3% five weeks before the cohorts slaughtered 
entirely. After the waning of colostral antibodies, the pigs remained free of antibodies to swine 
influenza subtype HiNj. The presence of antibodies in the serum of the dams was detected against 
M  hyopneumoniae, swine influenza subtype HtN] and PRRSv. Given the dams were vaccinated for 
these three pathogens, it is not possible to conclude whether the positive sera indicated infection or if 
positive sera were solely related to the vaccination program.
Table 3.5 M  hyopneumoniae and PRRSv seroprevalence among 12 cohorts of growing pigs
Pig Age (days)
Prevalence
M hyopneumoniae PRRSv
30 87.78 21.11
60 13.70 9.72
90 1.15 98.85
120 22.22 100.0
140 33.33 100.0
3.5 Part III: The effects of risk factors identified in the literature as associated with finishing 
mortality and substandard pigs
Hot weather (season), feed antimicrobials, degree of age segregation and, M. hyopneumoniae 
vaccines were associated or suggested to be associated with mortality or substandard pigs in the 
literature review (Chapter 2). Estimates of mortality rate and substandard pig rate were summarized 
by cohorts based on the performance data, to assess whether these factors were putative risk factors 
for mortality and substandard pigs. Analysis of variance was applied to compare the effect of three
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potential risk factors: 1) administration of tilmicosin 2) sex 3) season. When a complete statistical 
model could not be obtained, the average performance were compared but not tested statistically.
I his is the case for two possible risk factors 1) presence of pig from an older age cohort present on a 
site at the time of placement and differing 2) M. hyopneumoniae vaccine given to different cohort of
pigs.
3.5.1 Definition o f  performance ratios
All comparisons were made using two performance ratios 1) mortality rate and substandard pig rate. 
The mortality rate used by the author, applied to a cohort of finisher pigs, raised from 10 to 26 weeks 
of age. Mortality rate was calculated as the number of dead pigs during the entire finishing phase, 
divided by the number of pigs placed in the finisher bams. Data used to calculate the mortality rate 
were available from the closeout reports.
The substandard pig rate used by the author, applied to two cohorts of pigs from the same sex, raised 
from 10 to 26 weeks of age. Substandard pig rate was calculated as the sum of substandard pigs in 
the two cohorts of the same sex pigs, divided by the sum of pigs placed in these two cohorts of pigs. 
For efficient barn utilization, substandard pigs, were sometimes transferred to another cohort of pigs 
of the same sex. Thus, accurate counts of substandard pigs were available by combining two 
cohorts.
3.5.2 Inclusion criteria
We retained only closeout reports with cohorts in the finisher phase between 90 and 120 days and 
with an average weight at placement between 25 and 35 kg. Consequently, comparisons of mortality
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rates were made from 468 of 563 closeout reports available from March 1996 to December 2000.
For efficient bam utilization, substandard pigs, were sometimes transferred to another cohort of pigs 
of the same sex. Thus, accurate counts of substandard pigs were available by combining two cohorts 
(pairs of the same sex). Comparisons of substandard pig rate were made from 75 of 87 pairs of 
closeout reports available during the period.
3.5.3 Effect o f  season and sex on mortality rate and substandard pig rate
Based on a visual assessment of an eight-week rolling average, mortality and substandard pig rate 
appeared higher in cohorts placed in the fall and/or winter seasons (Figure 3.2). A peak in mortality 
rate and substandard pig rate was observed on the following weeks: weeks of October 14th, 1996, 
December 1st, 1997, October 12th, 1998, September 13th, 1999 and October 9th, 2000 (Figure 2, 
Figure 3).
Figure 3.2: Mortality rate observed in cohorts of pigs raised between 10 and 26 wreeks of age
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Figure 3.3: Substandard pig rate in cohorts of pigs raised between 10 and 26 weeks of age
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Circles show the actual weekly mortality rate, and the doted line shows the eight-week rolling average.
To determine if this apparent effect of season was statistically significant, four quarters of 13 weeks 
each were created, with quarter one starting January7 P l. Analysis of variance w7as used to model the 
effect of the quarter and year when pigs w ere placed, the sex of the cohort of pigs and the 
interactions between these three fixed effects. But mortality rate and substandard pig rate showed a 
parametric distribution after square root transformation.
The median mortality rate was 5.44%. Quarter had a significant effect on mortality rate but differed 
each year, as indicated by the significant interaction ot quarter and year (p^arter*)ear 0.0001). As 
shown in Figure 3.4, mean mortality rate peaked during quarter four for cohorts of pigs raised in 
1997, peaked during quarter three of year 1998 and quarter three of year 1999. Sex had an effect on 
mortality rate (p < 0.0001) but did not interact with quarter or year. The mean mortality rate was
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6.42% and 4.48% tor castrated males and gilts respectively. The SAS output for this analysis can be 
found in appendix B, at the end of this thesis.
Figure 3.4: Mean and standard error of mean mortality rate as a function of year and quarter of entry 
into finisher bams
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The median substandard pig rate was 5.72% for the period between quarter three of 1997 and quarter 
three of year 2000. The effect of quarter on the substandard pig rate was significant and differed 
over years ( p year*quartcr < 0.0001). Quarter three was not consistently associated to peak substandard 
pigs rate. Substandard pig rate peaked in quarter one of 1998 and quarter three of 1999 (Table 3.6). 
Results from only two quarters were available in 1997 and only 3 quarters were available in 2000.
Year when batch was placed
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Table 3.6 Mean substandard1 pigs rate3 by year and the quarter4 of the year
Year Quarter1 NJ Mean St deviation
1997 3 2 0.251 0.014
1997 4 6 0.247 0.036
1998 1 5 0.304 0.050
1998 2 7 0.200 0.030
1998 3 6 0.296 0.059
1998 4 7 0.265 0.089
1999 1 6 0.167 0.060
1999 2 7 0.258 0.049
1999 3 6 0.303 0.053
1999 4 6 0.254 0.047
2000 1 6 0.208 0.015
2000 2 6 0.195 0.022
2000 3 5 0.167 0.015
'Substandard pigs which is defined a pig sold to the slaughter market at 26 weeks of age at a live weight lower than 99.8 
kg
~N: number o f pairs o f same sex cohorts of pigs observed
^Substandard rate is calculated as the total number o f substandard pigs produced per tw o cohorts o f the same sex pigs, 
divided by the total number o f pigs placed in the same two cohorts o f pigs.
4Quarter 1 starts January' 1st and a quarter is 13 weeks
3 5.4 Effect o f  feed antimicrobials on mortality rate and substandard pig rate
The mean mortality rate during times when pigs were given certain feed antimicrobial regimens was 
lower than others (Table 3.7). The overall goal in feeding antimicrobials was to reduce the severity 
of the clinical signs or to delay the onset of clinical signs. Between January, 1997 and December. 
2000, the feed antimicrobial regimens changed thirteen times. The changes were implemented 
sequentially without using negative concurrent control cohorts ot pigs. Further, antimicrobial 
regimens were not repeated at different time ot the year, and the number ot cohorts ot pigs treated 
was limited.
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Table 3.7 Feed antimicrobial applied to each feed ration for pigs between 3 and 10 weeks of age 
(nursery) and for pigs between 10 and 26 weeks of age (finisher)
No. NU RSER Y FINISHER Period Median mortality 
rate
52 NT* NT T Y 240 T Y 40 1 Y40 TY40 T Y 100 TY40TY40 I Jan 97 -  Jun 98 3.231
23 M CX450 M C X 50 M C X 50 M CX50 I TY40 TY40 TY100 T Y 40T Y 40  I Jun 97 -  Sep 98 5.524
61 M C X 50 M C X 50 M C X 50 M CX50 1 LI540 L I200LI40 LI40 LI20 R6 Sep 98 -  Mar 99 7 .749
16 M C X 50 M C X 50 M C X 50 M CX50 I TY40 TY40 TY40 n 7 n N Mar 99 -  May 99 8.625
27 PU*363 PU363 T Y 40 T Y 40 R TY40 TY40 TY40 N N N May 9 9 -  Aug 99 5.918
41 PU363 PU363 T Y 40 T Y 40 R TY40 TY20 NO N N N Aug 99 -  Dec 99 8.769
39 PU363 PU363 T Y 40 T Y 40 R TY40 TY20 PU181 BM D BM D R Dec 99 -  Mar 00 6.306
24 PU363 PU363 T Y 40 T Y 40 R T Y 40D C 9 B M D 10 BM D BM D R Mar 00 -  May 00 4.064
16 PU181 PU181 T Y 4 0 T Y 4 0 R TY40 DC BMD BM D BM D R May 00 -  Jun 00 4.248
16 PU181 PU181 T Y 4 0 T Y 4 0 R TY40 TY40 BMD BM D BM D I Jun 0 0 -  July 00 6.585
21 PU181 PU181 M CX25 M CX25 R TY40 TY40 BM D BM D BM D I Jul 00 -  Aug 00 4.086
52 PU181 PU181 M CX25 M CX25 R TY40 TY20 TY40 DC TY40 R Aug 00 -  Nov 00 5.290
6 PU191 PU181 T Y 4 0 T Y 4 0
• .. '2 ^  r—  ‘
R TY40 DC BMD 
T
BM D BM D R
T 7 T
Nov 00 -  Dec 00  
. F - -
5.107
N: no feed antimicrobial;8 PU: tilmicosin;Q DC: tiamulin combined with chlortetracycline; 1 BMD: bacitracin 
methylene disalicylate
For purpose of comparison, feed antimicrobials were coded by growth phase (nursery or finisher), 
and by pathogen targeted. The author assumed that neomvcin/terramycin. tylosin, carbadox. 
bacitracin methylene disalicylate targeted intestinal pathogens while lincomvcin. tilmicosin and 
tiamulin combined with chlortetracycline primarily targeted pathogens affecting the respirator)'
system.
For mortality rate, the difference between the worst performing teed antimicrobial regimen and the 
most protective feed antimicrobial was 5.53%. The introduction ot tilmicosin as a nursery teed 
antimicrobial was concurrent with decreased mortality rate, and the inclusion ot tiamulin in the 
finishing phase was concurrent with another drop in mortality rate (Figure 3.5).
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Figure 3 .5 :1 he 25th, 50th and 75th percentile mortality rate for cohorts of pigs fed antimicrobial 
regimens targeting either respiratory or enteric diseases in nursery and finisher production phases
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R indicates the antimicrobials in feed intended to control respiratory' pathogens, while 1 indicates the antimicrobials in 
feed intended to control intestinal pathogens and N indicates the absence o f antimicrobial in the feed.
These data suggested that feeding antimicrobials targeting respiratory pathogens might reduce the 
mortality rate. Consequently, further investigation on the effect of feed antimicrobial on mortality 
rate and substandard pig rate was warranted.
A review of the minimum, median, and maximum substandard pig rate categorized by teed 
antimicrobial type suggests that the use of feed antimicrobial targeting respiratory pathogens in the 
nursery is associated with a lower substandard pig rate (Figure 3.6). However, only tour 
observations were available to estimate the effect of feed antimicrobials targeting intestinal pathogen
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while in the nursery and no feed antimicrobial while in the finisher. Consequently, these findings 
should not be regarded as conclusive due to insufficient data.
Figure 3.6: 25th, 50th, and 75th percentile substandard pig rate for cohorts of pigs fed antimicrobial 
regimens targeting either respiratory' or enteric diseases
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3.5.5 Ejfect o f  tilmicosin on mortality and substandard pig rate
Pigs were either fed diets medicated with tilmicosin at 330 PPM from weaning to 11 kg followed by 
tylosin at 36 PPM from 11 to 25 kg (Treatment A) or were fed diets medicated with carbadox at 45 
PPM from weaning to 25 kg (Treatment B). Pigs in treatment B were vaccinated at 5 and 7 weeks of 
age using a A/. hyopneumoniae vaccine1. All pigs were vaccinated with a commercially available.
1 M+Pac, Shering Plough, Kenilworth, NJ
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modified live PRRSv vaccine1 at nine weeks of age. Following the initial six weeks medication 
period, pigs in treatments A and B were fed diets medicated with tylosin at 36 PPM for 8 weeks. 
Non-medicated diets were fed for the remaining of the finishing phase.
The hypothesis of no differences in mean mortality rate between treatments was measured using 
student 1 -test2, paired on the basis of sex of the cohorts of pigs and the week when pigs were placed 
in the finisher. The cohort of pigs was the study unit. Statistical significance wras set at value less 
than 0.05 (two sided). The hypothesis of no differences in mean substandard pigs rate between 
treatments was analyzed similarly.
The mean mortality rate for pigs in treatment A was 8.1% and was 9.5% for pigs in treatment B (p = 
0.47). The substandard pig rate for pigs in treatment B (26.4%) was more than double that for 
treatment A (12.7%) (p = 0.04).
Table 3.8 Average mortality rate and substandard pig rate for cohorts of pigs receiving tilmicosin 
from weaning to 11 kg (Treatment A) and cohorts of pigs vaccinated against M. hyopneumoniae and 
receiving carbadox from weaning to 11 kg (Treatment B).
Treatment No. Cohorts Mortality rate Substandard pigs
(%) rate (%)
_ _  _ _  —
B 6 9.5 26.4
P value 0.47 0.04
A: Treated pigs, fed 330 PPM o f tilmicosin from weaning to 11 kg, followed with 36 PPM tylosin from 11 to 25 kg and 
not vaccinated for M  hyopneumoniae
B: Control pigs, fed 45 PPM of carbadox from weaning to 25 kg and vaccinated with M  hyopneumoniae at 5 and 7 
weeks of age
1 ResPRRS, Boehringer Ingelheim Vet Medica, St-Joseph, MO
2 StatSoft, Inc. (1999) Tulsa OK Statistica Release 5.5
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3.5.6 Apparent effect of degree of age segregation at the level o f a site at the time o f pig placement 
on mortality rate and substandard pig rate
A finishing site was filled with pigs weaned over two weeks. Figure 3.7 shows the historical 
(January to May 1999) mean mortality rate based on the position of the cohorts on the finishing site. 
I he first pigs entering the site were placed on the south-most four finishing bams, farthest away 
from the employee's office. Pigs placed during the second week were placed in the north-most four 
finishing barn, those closer to the office. In consequence, pigs entering a site first (on the south side 
of the site) were placed while pigs from the previous cohorts were still present on the site. Pigs 
entering the site during the second week were placed while 10 weeks old pigs were present on one 
end of the finishing site.
Figure 3.7: 25th, 50th, and 75th percentile mortality rate for cohorts placed between January 1999 
and May 1999
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I wo weeks o f weaned pig production filled a finishing site, the first week ot production being placed North and the 
second week o f production being placed South on the finishing site.
Mortality rate tor cohorts placed north was 6.85% and the mean mortality rate for cohorts of pigs 
placed on the south side ot the finishing site was 8.66%. Based on these differences in mortality 
rate, we hypothesized the level of segregation affected the mortality rate (Scheidt et al., 1995).
I o estimate the ellect ot pig placement on mortality and substandard pig rate, we first assigned ten 
weeks ot production to a completely empty and clean site. The next ten weeks of production were 
then placed in a finisher site where slaughter age pigs were present. Finally, we placed the next ten 
weeks of production to a finisher site completely cleaned and free of pigs. In total, 30 weeks of 
production were included.
The mean mortality rates were 9.15%, 6.24% and 10.46% respectively while the mean substandard 
pigs rates were 4.89%, 3.82% and 10.45%, respectively for each of the three sequential 10-week 
blocks. Although we could test statistically these findings, these data were consistent with the 
hypothesis that level of age segregation affected mortality rate. Cohorts of pigs placed on a site 
where older pigs are 11 weeks of age results in lower mortality rate than cohorts of pigs placed on a 
finishing site where the older pigs already present are 26 weeks ot age.
3.5. 7 Effect o f  the brand ofM. hyopneumoniae vaccine on mortality and substandard pig rate 
The use of M hyopneumoniae vaccine was concurrent to lower mortality rate, when compared to 
time periods when M. hyopneumoniae vaccine was not used (1 able 3 .9). Pigs were vaccinated 
during most of the study period, but the brand of Mycoplasma vaccines \aried. Regardless ot the 
vaccine brand, pigs were vaccinated for M. hyopneumoniae at five and at se\en weeks ot age. No
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cohort were kept as concurrent non-vaccinated controls. Because we had no concurrent control 
cohorts, statistical testing was not possible using conventional methods. We therefore compared the 
median mortality rate and the median substandard pig rate based on the brand of M. hyopneumoniae 
vaccine without applying statistical tests. The period and chronology for which we used each M. 
hyopneumoniae vaccine brand is presented in Tables 11 and 12 with the 25th, 50th. and 75th 
percentiles for morality rate and substandard pig rate.
All cohorts vaccinated for M. hyopneumoniae had numerically lower median mortality7 rates than 
cohorts not vaccinated (1 able 3.9). The overall median morality rate was 6.2%. The median 
mortality rate was numerically lower for cohorts vaccinated with Respisure® or cohorts vaccinated 
with an autogenous vaccine when compared with non-vaccinated periods.
Fable 3.9 Mortality rates in the commercial pig production system under study by time and A/. 
hyopneumoniae vaccine brand used
Vaccine Brand No. Of cohorts Period Used Percentile Mortality
(N) Rate
25th
so
75*
Respisure® 1 June 97 -  July 98 140 2.1 5.32 14.9
Respifend® 2 July 98 -  Oct 99 29 2.2 7.57 8.1
M+Pac®’ Nov 98 -  April 98 55 6.8 8.74 11.2
MVP4 April 99 -  Aug 99 127 3.6 6.66 6.7
None5 Aug 99 -  Dec 99 65 5.1 9.02 10.7
Mh/Past6 Jan 00 -  March 00 11 4.7 6.40 9.1
'Respisure, Pfizer (Exton, PA)
Respifend, Foil Dodge (Fort Dodge, IA)
M+Pac, Schering Plough (Kenilworth, NJ)
‘Autogenous, MVP(Ralston, NE)
5No vaccine
Autogenous vaccine M. hyopneumoniae and Pasteurella multocida, Newport (Worthington, MN)
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I he substandard pig rate increased concurrently with the use of Respifend® vaccine, and peaked 
with the use of M+Pac® vaccine. With the exception of the period of M+Pac® vaccine use, the 
substandard pig rate was lower during periods of vaccination then the period where no M. 
hyopneumoniae vaccine was used.
I able 3.10 Substandard pigs rate associated with time and the M. hyopneumoniae vaccine brand 
used in the segregated production system under study
Brand Period Used N Percentile
25th 50th 75th
Respisure® 1 June 97 -  July 98 19 4.6 5.6 8.2
Respifend®2 July 98 -  Oct 99 6 5.1 6.1 9.2
M+Pac®J Nov 98 -  April 98 10 10.6 8.3 13.0
MVP4 April 99 -  Aug 99 20 2.7 3.5 4.7
Nomr Aug 99 -  Dec 99 15 4.7 7.5 9.6
Mh/Past6 Jan 00 -  March 00 2 7.1 _
‘Respisure, Pfizer (Exton, PA)
Respifend, Fort Dodge (Fort Dodge, IA)
M+Pac, Schering Plough (Kenilworth, NJ)
‘Autogenous, MVP(Ralston, NE)
5No vaccine
Autogenous vaccine M. hyopneumoniae and Pasteurella multocida, Newport (Worthington. MN)
Other control measures were changed during the study period, including changes in feed 
antimicrobials and cessation of PRRSv vaccine. Although these concurrent changes and seasonal 
effects may have contributed to changes in mortality rates, these data suggest that M  
hyopneumoniae vaccine may have a beneficial ettect ot on mortality rate. 1 he large difference 
between the mean mortality rate from cohorts not vaccinated and cohorts vaccinated warrants lurther 
evaluation.
I he two different data set studies indicate that feed antimicrobials targeting respiratory' pathogens 
improve mortality and substandard pig rates. Feed antimicrobials targeting respiratory pathogens 
during all growth phases tended to reduce mortality (median mortality rate of 50 pigs / 1,000 pig 
placed) when compared with therapy against enteric pathogen (median mortality rate of 80 pigs 
/ l ,000 pig placed). The period before September 1998 (exceptional period when feed antimicrobials 
targeting intestinal pathogens resulted in lowest mortality rate (median mortality rate of 40 pigs 
/ l ,000 pig placed) correspond to a time when the production system was not fully populated. 
However, it must be noted that the declining mortality rate approximately coincided with the 
cessation of PRRS modified live vaccine given at nine weeks of age and the introduction of rolled 
mill feed in the form of meal for pigs between 23 to 41 kg. Unfortunately, the small sample size and 
for some treatment the absence of concurrent negative control prevented us to draw firm conclusions 
from these data.
The non significant favorable difference in mean mortality rate between cohorts receiving tilmicosin 
and cohorts not receiving tilmicosin but vaccinated for M. hyopneumoniae (8.1% and 9.5%, 
respectively) has been reported in other studies comparing the mortality rate of cohorts of pigs 
receiving tilmicosin or cohorts of pigs receiving tiamulin combined with chlortetracycline (1 able 
2.1). Since M. hyopneumoniae vaccine was administered concurrently with the feed antimicrobials, 
it is not possible to conclude that there was a direct association between lower mortality rate and the 
use of vaccine. Briksen reported a 61.3% (2000) lower mortality rate and Harker repoited a 1.79% 
lower mortality rate for pigs treated with tilmicosin (1999).
3.6 Discussion
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For the five periods where different M. hyopneumoniae vaccines were used, the reduction in 
mortality rate, relative to the periods when no M. hyopneumoniae vaccines were used ranged 
between 3.1 % and 4 1.0%. 1 his range of protective effect is within the range of effect reported in the 
literature (Table 1.1). Studies using cohorts of pigs as study units and infected with both M. 
hyopneumoniae and PRRSv showed positive effect of M hyopneumoniae vaccine of 5.75% (p > 
0.05) (Maes et al., 1999), and 60.7% (p < 0.05) (Pallares et al, 2000). Different vaccine brands were 
used at different time periods. The numerical effect of mycoplasma vaccine on substandard pig rate 
ranged between 10.7% and 53.3%. However, the effect of M. hyopneumoniae vaccine on 
substandard pig rate has never been reported and so deserves further investigation.
Although many aspects of this study point towards an effect of complicated mycoplasmal 
pneumonia on mortality rate, the direct role of PRRSv is unclear as twenty7 samples collected at 30. 
60, 90. 120 and 140 days of age from twelve cohorts raised during the 1999 documented that pigs 
become positive to PRRSv at approximately 50 days of age.
The overall mean mortality rate of 6.2% recorded during the four years of this study is similar to the 
mean mortality rate of 6 . 1% reported for a system with a similar size and production process (Maes 
et al., 2001). However, these findings contrast with a weighted national mean mortality of 2.3%, 
reported in national survey conducted in 1995 on US cohorts of finishing pigs (Losinger et al.,
1998). Based on the distribution of the national survey, a mortality rate of 6 .2% correspond to the 
mortality rate for a farm system in the 96.8th percentile of farms in the nation-wide survey (Losinger 
et a l, 1998).
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I his study showed that natural variables such as sex and season could affect mortality rate. Little has 
been reported about the biological explanations for lower death loss in cohorts of females compared 
to cohorts of castrated barrows (4.48% versus 6.42%) and lower death loss for cohorts of pigs sold 
between January and June. 1 he quarters with higher mortality rates (quarter three and quarter four) 
corresponded to quarters receiving pigs that were bom between December and April, the typical 
period of seasonal infertility. During that period of seasonal infertility, quality standards of age and 
weight for weaned pigs were not strictly enforced, in an attempt to meet production goals. It is 
therefore possible that these seasonal trends in mortality rates were, in part indirectly attributable to 
quality standard for weaned pigs placed in the finisher production phase or related to a direct 
seasonal effect during the finishing period. In addition to the unfavorable effect of seasonal 
infertility, pigs sold during quarter three and quarter four, grew during the warmest period of the 
year (July to September), which could potentially explain a direct risk of death. Here, risk of death 
could be caused from heat stress or stomach ulcer, related to off feed period, when pigs are exposed 
to elevated temperature (Argenzio and Eisemann. 1996). Consequently, these factors should be 
considered when setting production targets and prior to designing incentive programs or concluding 
on the favorable effect of an intervention where comparison ot treatments are made over time, 
without concurrent controls.
Even though not statistically evaluated in this study, the observation ot a 36.3% decrease in 
mortality and 28.0 to 63.4% in substandard pig rate when finishing barn sites were managed in strict 
segregated basis is consistent with the notion that strict age segregation may reduce mortal it) rate, 
presumably through improved disease and prevention control and is a reminder that husbandry 
practice may have an effect on zootechnique performances as large as therapeutic interv entions.
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Segregated production has been associated with decreased pneumonia lesions and increased 
performance (Scheidt et al., 1995).
This study did not yet clearly define the etiologies of mortality and substandard pig performance. 
However, a decrease substandard rate of 14.3% in response to tilmicosin therapy, combined with the 
tendency toward reduced mortality rate in cohorts of pigs vaccinated to M. hyopneumoniae, suggests 
that respiratory disease may affect mortality rate and substandard pig rate. This observation 
warrants the need for further study.
4 LITERATURE REVIEW OF M Y C O P L A SM A  H Y O P N E U M O N IA E
4.1 Introduction
Use of M hyopneumoniae vaccines was associated with periods of decreased death loss and 
substandard pigs rate (Chapter 3). Respiratory diseases have been to associated with increased 
mortality (Losinger et al., 1997). What follow7 is a review of the literature of M  hyopneumoniae as a 
potential causes of mortality.
4.2 Etiology
Goodwin and Mare simultaneously identified M. hyopneumoniae as the infectious cause of 
pneumonia in 1965 (Goodwin et al., 1965; Mare and Switzer, 1965). M. hyopneumoniae is prevalent 
in most countries, with 38% to 92% of pigs showing grossly observ able pneumonic lesions at 
slaughter (Guerrero, 1990). M. hyopneumoniae is considered a primary infectious agent. More 
recently, co-infections of M. hyopneumoniae with Pasteurella multocida (Amass et al., 1994). 
Streptococcus suis (Halbur, 1998), sw ine influenza virus (Thacker et al., 2001), and Porcine 
Reproductive and Respiratory Syndrome virus (Thacker et al., 1999) have been documented. M. 
hyopneumoniae infections, when combined with secondary bacterial or viral infections, have been 
referred to as complicated mycoplasmal pneumonia (Veenhusizen, 1998).
4.3 Economic importance of M . hyopneum oniae
K1. hyopneumoniae is recognized as an economically important disease because of the detrimental 
el feet it has on average daily gain (ADG) and teed efficiency (FE) (Pointon et al., 1985).
Complicated mycoplasmal pneumonia can increase mortality rates in addition to affecting ADG and 
FE (Straw et al., 1999). Although not documented directly in the scientific literature, M  
hyopneumoniae may reduce the proportion of pigs sold to the slaughter market through its effect on
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ADG. Often the slowest growing pigs cannot reach full market weight in a segregated production 
system (Gourley, 1998).
4.4 Lffect of mycoplasmal pneumonia on growth rate, in relation to size of pneumonic lesions
The detrimental effect of pneumonia on ADG is inconsistent in the scientific literature, with 
significant detrimental effect on ADG in 13 of 23 studies reported in a literature review (Morrison et 
a l, 1986). Variation in the effect of pneumonia on daily weight gain was attributed in part to 
differing study designs and the methods used for measuring the proportion of lung with pneumonic 
lesions (pneumonia score) (Morrison et a l, 1986 ; Scheidt et a l, 1992). Straw reviewed 27 studies 
that measured the effect of pneumonia on growth rate and efficiency of feed utilization was 
associated with a decrease in ADG. Across all 27 studies, a 10% increase in pneumonia lesion score 
at slaughter, the ADG decrease by 37.4 g/d (Straw et al.. 1989).
Studies that have categorized the extent of pneumonic lesion into severe or mild categories have not 
used standard definitions for the categories. The minimum pneumonia score categorized as severe 
was 40% in one study (Stark et al., 1998) while in another study, the minimum pneumonia score 
considered severe was 75% (Pointon et al., 1985a). Differences in definitions may explain pan of 
the variable conclusion drawn in regards to the association of the size of the pneumonic lesion and 
growth rate. In an effort to establish a precise method of measurement. Hill measured pneumonia 
lesions by calculating the volume rather than the surface area ot the lung aliected (Hill et al., 1992; 
Hill et al., 1994). The volume of lung affected by pneumonia at slaughter was inversely associated 
with the days to 104.5 kg, suggesting that the size of pneumonic lesion at slaughter may not be 
directly related to depressed growth rate (Hill et a l, 1992; Hill et a l, 1994).
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Justifications tor the relationship between heavy pigs and high proportion of lungs showing 
pneumonia is likelv due to recent infection, which did not affect the pig over a long enough period of 
time to challenge its growth rate (Morris et al., 1995; Hill et al., 1994;Wilson et al., 1986; Clark et 
al., 1990). Authors who studied the relationship between average lifetime pneumonia (i.e. average 
of pneumonia lesions estimated by X-Ray) and weight at 180 days, estimated the coefficient of 
determination between 39% (Noyes et al., 1990) and 43% (Sitjar et al.. 1996). These coefficients are 
larger than the coefficient of determination associating pneumonia score at slaughter and weight at 
180 days, reported in three studies: 14% (Noyes et al.. 1990), 44% (Morris et al., 1995); 26% (Sitjar 
et al., 1996). Sitjar demonstrated that pneumonia lesions resolved over time and thus on some 
occasions, larger pneumonia lesions can be associated with late infections and heavier pigs (Sitjar et 
al., 1996).
4.5 Pathogenesis and host immune response: protective role of the humoral immune system
The pathogenesis of M. hyopneumoniae is initiated by the adhesion of the bacteria to the cilia of the 
tracheal epithelium, the bronchi and the bronchioli, followed by intense colonization (Blanchard and 
Kobisch, 1995). The bacteria produce a cytopathic factor causing the loss of cilia and the 
destruction of the epithelial cell, eventually resulting in the production of a measurable humoral 
response and the modulation of the host immune response.
M. hyopneumoniae enhances T suppressor cell activity and produces a mitogenic substance tor 
lymphocytes (Young et al., 1989), which at the same time, reduces the capacity of the lymphocytes 
to produce antibodies, thus reducing the phagocytic response of porcine alveolar macrophages 
( I ajima et al., 1984). In an experimental study, Messier described the cellular and humoral immune 
response of pigs from 0 to 8 weeks post A/. hyopneumoniae inoculation (Messier et al., 1990). IgA
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and lg(i aie both involved locally. Early in the response, IgA is more prevalent in lung tissues, 
overcome later by IgG. IgG can also be found in greater proportion in serum. IgM appears to plav a 
minor role as their presence is only seen in bronchial lymph nodes and inconsistently seen in serum, 
and are generally associated with a non-specific response. Messier s work showed that although 
cellular immunity was detected by a lymphocyte stimulation test, the development of the humoral 
response better parallels the onset ol recovery from the disease, particularly IgA in lung washings 
(Messier et al., 1990). I-urthermore, Debey showed that cytopathogenicity of M. hyopneumoniae on 
tracheal rings wash was suppressed by porcine serum (DeBey and Ross, 1994), and Lam 
demonstrated that passively transferred serum containing antibodies to M. hyopneumoniae protected 
swine against development of pneumonia, confirming that circulating antibodies are involved in the 
protective mechanism (Lam and Switzer. 1971).
The ability of M. hyopneumoniae to modulate the immune system can explain the association 
between M. hyopneumoniae and secondary infection such as Streptococcus suis (Halbur. 1998), 
Pasteurella multocida (Amass et al., 1994). The detrimental effect of M. hyopneumoniae on PRRSv 
is proposed by some authors (Thacker et al., 1999). Lung lesions indicative of PRRSv infection 
were more severe in pig infected with M. hyopneumoniae prior to being infected with PRRSv 
(Thacker et al., 1999) and were reduced in pigs vaccinated with M. hyopneumoniae prior to being 
challenged with M. hyopneumoniae and PRRSv (Thacker et al., 2000). Although, this relationship 
was not documented by another w7ork with similar aims (VanAistine et al., 1996). Many 
mechanisms of action have been hypothesized, ot which. A/ hyopneumoniae attraction ot 
inflammatory cells may produce an ideal environment lor a PRRS\ induced inflammation to persist 
(Thacker et al., 1999). This environment is partly created by the ongoing infection of monocytes
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recruited by M  hyopneumoniae. Monocytes are then available for replication of PRRS virus
(Mengeling et al., 1996).
A marked variability in the strength of the antibody response among infected pigs has been 
described (Bereiter et al., 1990). The persistence of passively acquired antibody in the piglet is 
correlated with the sero-status of the sow. For piglets with initial antibody concentration classified 
as low (optical density of 0.6), medium (optical density of 0.9) or high (optical density of 1.8), the 
antibodies wane at 30, 45, and 63 days, respectively (Wallgren et al.. 1998). However, there is not a 
perfect dose response relationship between the sow’s and the newborn piglet’s titer. Several external 
factors such as sucking behavior, competition among littermates, milk production, and nursing 
behavior, can influence colostral intake. The median half-life of maternally derived M 
hyopneumoniae antibodies is 15.8 days (Morris and Gardner, 1994).
The important mycoplasmal immunogens are thought to reside in the glvcocalyx and the cell 
membrane of the bacterium. At present, there is inadequate information to indicate which 
immunogens are directly related to the protective effect induced by mycoplasma vaccine. 
Immunoglobulins found in the serum of vaccinated or recovering pigs are identified by the 
molecular weight of the proteins. Proteins of size 110, 64, 50, and 41 kDa (Ross et al., 1984); 40 
(Kobisch et al., 1993) 74 , 46 (Frey et al., 1992) have been reported. This immune response prevents 
pigs from being re-infected within 14 weeks after the initial challenge (Kobisch, 1993). Vaccines do 
not all stimulate the same protein as only two of four vaccines stimulated the protein of 97 kDa 
(Thacker et al., 1998).
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4.6 The diagnosis of M . hyopneum oniae
Diagnosis ot M. hyopneumoniae should be confirmed by the presence of clinical signs, and 
macroscopic lesions indicative ol M. hyopneumoniae and by the direct evidence of the organism in 
the tissues by PCR, immuno-fluorescence, direct enrichment, or by the indirect evidence of M.
hyopneumoniae antibodies.
4.6.1 Clinical signs o f complicated mycoplasmal pneumonia
Severity of the clinical signs depends on the presence of a secondary’ infection and environmental 
factors. The clinical presentation of complicated mycoplasmal pneumonia includes the following
signs.
1) dry hacking cough is the landmark signs of enzootic pneumonia (Fenstra et al., 1994).
2) productive cough, inconsistent coughing over 8 to 10 weeks post infection (Clark et al., 1991)
3) fever
4) anorexia
5) labored breathing or thumping, and prostration
6 ) retarded weak growth
7) high morbidity and increased mortality rate (Straw7 et al., 1999)
8 ) heterogeneous body condition cohorts of pigs infected with a high proportion of unthrifty pigs 
c^) increased rate of pale pigs secondary to bleeding gastric ulcers
Although pigs of all ages are susceptible to M. hyopneumoniae infections, clinical signs are more 
frequently seen in pigs between 12 to 20 weeks of age (Leon et al., 2001, Andreasen et al., 2000,
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Seok and Joo, 1999). Conjunctivitis, thumping, and gastric ulcers, observed in field infections are 
not directly related to M. hyopneumoniae infection but rather to the resulting secondary infection 
(Maes et al., 1996; Straw et al., 1999). Increased mortality and heterogenous growth pattern have 
not been routinely documented in the literature.
4.6.2 Macroscopic lesions o f  complicated mycoplasmal pneumonia
Macroscopic lesions ot complicated mycoplasma are not specific since similar lesions may be seen 
in pneumonia caused by other agents (Armstrong et al., 1984). These lesions can be characterized in 
the following ways:
1) Catarrhal pneumonia is found in the ventral portion of the cranial, middle or accessory7 lobes and 
in the cranial portion of the caudal lobes.
2) Atelectic purple to gray areas of consolidation is present in the cranio-ventral portions of the 
lung (Straw et al., 1999). Often, bronchial and mediastinal lymph nodes are enlarged in the 
chronic stage.
3) Lesions resolve and consequently, early infections are not detected at slaughter. Two to four 
weeks post infection, macroscopic lesions are maximal. Macroscopic healing starts and it no 
secondary infections occurs, only a few macroscopic lesions remain at ten weeks post infection 
(Maes et al., 1996). Secondary infections can markedly influence the lesions, as the 
inflammation becomes more pronounced.
4) Two to four weeks post infection peribronchial cutting appears. Eight weeks post infection, 
cuffing begins to disappear (Maes et al., 1996).
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5) A man tu showed in a sequential evaluation of pigs following intra tracheal infection of M. 
hyopneumoniae that direct immunofluorescence is most intense at four to six weeks post 
infection and tends to decrease by eight to twelve weeks post infection (1984).
Because of their long duration, macroscopic lesions persist longer than the antigen can be detected 
by direct immunofluorescence on lung tissues (Amanfu et al., 1984). Once M hyopneumoniae 
presence is confirmed in the herd, sero-diagnostic tools are most frequently used. Under this 
scenario, the purpose of serologic testing is no longer for etiologic diagnosis but to characterize the 
infection including description of the onset, duration of the infection.
4.7 Intervention strategies
4.7.1 Antihiotherapy
Assuming early onset of infection result in lower ADG. different control strategies, aiming at 
delaying the onset of infection were developed. The fact that M. hyopneumoniae possesses no cell 
membrane (Tully et al., 1993) makes this organism resistant to antibiotics using the enzymatic 
destruction of the cell membrane as a mechanism of action (B-lactam). Based on in vitro testing, the 
antibiotics with mycoplasmacidal activity include tetracycline; (Daniels et al., 1998), tiamulin 
(Goodwin, 1985), tylosin (Ter Laak et al., 1991), lincomycin (Ter Laak et al., 1991), spiramycin, and 
the newer quinolones (Inamoto et al., 1994).
1 he bacteriostatic or bactericidal activities ot feed antimicrobials commonly used in the control ot 
complicated M. hyopneumoniae also have an effect on secondary bacterial agents such as 
Pasteurella multocida, and Arcanobacterium pyogenes and thus can improve performances through
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direct activity on M. hyopneumoniae and these secondary' bacterial invaders. In addition to its direct 
effect on \ t  hyopneumoniae, tilmicosin increases the incidence of apoptotic polvmorphonuclear 
neutrophils rather than their necrosis (Chin et al., 2000; Golstein, 1991; Wyllie, 1997). The 
phagocytosis of apoptotic polymorphonuclear neutrophils by macrophages plays a key role in the 
resolution of inflammation in the respiratory tract.
Feed antimicrobial strategies designed to control M. hyopneumoniae infections include pulse 
medication, medication using combined antimicrobials, and continuous feed medication. Pulse 
medication provides short-term medication at therapeutic doses separated by non-medicated 
intervals of variable length and frequencies. Pulse medication is intended to permit exposure to 
endemic pathogens, allowing stimulation of the immune system while abbreviating the incubation 
process, thus preventing them from reaching triggering infectious dose levels resulting in clinical 
signs (Walter et al., 1999).
Feed antimicrobials used either as pulse dosage or provided continuously can improve growth 
performance. Tiamulin or lincomycin used alone or in combination with tetracyclines, ted to pigs 
continuously or in pulses result in comparable rates of improvement in ADG, which appears superior 
to chlortetracycline alone. Combination of feed antimicrobials trend towards superior teed 
efficiency (Table 2.1). Tiamulin used alone is reported to improve ADG by 2.76% to 9.65% and 
feed efficiency by 0.90% to 9.60% compared to negative controls (Pointon et al., 1985; Pott and 
Edwards, 1990; Burch, 1984). Tetracyclines used alone were reported to improve ADG by 0% to 
3.73% and feed efficiency by 0.33% to 2.33% compared to negative controls (Burch et al., 1986; 
Gourley, 1998; Deen et al., 1999; Ice et al., 1999). Based on a retrospective study conducted on
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Japanese isolates ol M. hyopneumoniae, resistance in vitro to chlortetracycline can occur (Inamoto et 
al., 1994; W u et al., 1997). I iamulin or lincomycin used in combination with tetracycline is 
documented to have a synergistic effect (Burch et al., 1986) and is reported to improve ADG by 
1.48% to 9.70% and feed efficiency by 1.47% to 7.94% compared to negative controls (Le Grand 
and Kobisch, 1996; Hewett, 1998; Jouglar et al., 1993; Kavanagh, 1994; Burch et al., 1986). 
Lincomycin is reported to improve ADG by 3.13% to 9.60% and feed efficiency by 1.37% to 4.11 % 
compared to negative controls (VanBuren et al., 2001; Hewett. 1998). Pulse medication programs 
with tiamulin and tetracycline or with lincomycin are reported to improve ADG by 1.24% to 8.95% 
and feed efficiency by 1.76% to 3.93% compared to negative controls (Walter et al., 1999: Le Grand 
and Kobisch, 1996; Gourley, 1998; Ibayashi et al., 1990).
It is not clear if the control of complicated mycoplasmal pneumonia is better achieved through feed 
antimicrobials or through vaccination. Measured on an individual basis Stipkovits reported that 
ADG improves by 30% for pigs receiving feed antimicrobials (lincomycin or tiamulin) and ADG 
improves by 13% for vaccinated pigs (Stipkovits and Miller. 1993). Measured at the level of a pen. 
Le Grand reported that ADG improves by 1.56% for pigs receiving tiamulin and 2.04% tor pigs 
vaccinated against M. hyopneumoniae (Le Grand and Kobisch, 1996). Finally. Mateusen reported 
no difference in individual ADG or pen teed efficiency and mortality tor pigs vaccinated with M 
hyopneumoniae or treated with tilmicosin (Mateusen et al., 2001). Unfortunately, the sample sizes 
ot these three studies were insufficient to statistically test the etfect ot the treatments.
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In 1990, M hyopneumoniae vaccines became available commercially and since then, beneficial 
effects ot vaccination has been described in the scientific literature. However, inference from these 
studies in commercial production systems is not always applicable due to the relatively small sample 
size or the absence ol statistical tests, the presence of concurrent respiratory pathogens, the absence 
of consideration tor this seasonal effect or the presence of vaccinated and control pigs in the same 
airspace.
To estimate M. hyopneumoniae vaccine's protective effect, the literature was searched for M 
hyopneumoniae vaccine studies and selected all publications that met three criteria: 1) presence of 
control negative cohort of pigs 2) duration of studies representative of modern finishing production 
(~ 25 to 100 kg) 3) growth rate or feed efficiency data presented. Eight peer-reviewed publications 
and 12 non-peer reviewed publications met these criteria. The degree ot change associated to 
vaccination was calculated as the difference between negative controls and treatment over the 
average of the negative controls (Straw et al., 1989).
For each study. Table 2.1 presents the unit ol analysis, the challenge model, the presence or absence 
ot physical separation between vaccinates and control, and tor each variable, the percent change 
relative to the control and specified the studies where significance was reported (p-value lower than 
0.05). When a study included two or more treatments (different brands of vaccine or two different 
times of vaccination), the results of each treatment relative to control are presented.
4.7.2 Vaccination
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Figure 4 .1 Distribution of degree of change, relative to negative control in daily weight gain (ADG) 
for finishing pigs reported in 23 M. hyopneumoniae vaccine studies
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In summary, M. hyopneumoniae vaccine’s protective effect on daily weight gain tor pigs during their 
finishing phase is best estimated between 2% and 5%. Only seven ot 2j> studies reported an ettect ot 
vaccine on ADG superior to 6%. No obvious factors could explain why the ettect size was larger in 
these studies. Jensen conducted a meta-analysis, using twenty-tour studies, pro\ iding 46 trials and 
concluded that M. hyopneumoniae vaccine significantly increased ADG by j . 2 / o  (Jensen et al.,
2000). Considering the results of 23 studies selected based on the reported size of pneumonic lesion, 
there does not appear to be a strong relationship between the degree ot change in pneumonia 
prevalence or pneumonia score and the degree of change in daily weight gain comparing vaccinated
versus non-vaccinated pigs (Figure 4.2).
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Figure 4.2 Relationship between changes in average daily gain and lung lesion score
ADG = 1.6670 + 05873 * PNPR (r = 37924 R2 = 0.14 p = 0.13)
(Mean Score treatment - Mean Score control) / Mean Score control 
Degree of change in size of pneumonic lesion relative to control (%)
>cx Regression 
95% confid.
Comparison between pigs vaccinated and unvaccinated with M. hyopneumoniae vaccine in 18 trials
Across all studies reviewed for which mortality and teed efficiency data were reported, the median 
effect of M. hyopneumoniae vaccine on feed efficiency and death loss rate is improved by j.27% and 
35% respectively (Table 4.1). For the purposes of these calculations, study results were included 
regardless of the outcome of statistical testing.
A/, hyopneumoniae vaccines may be able to reduce the duration of infection and thus reduce the 
bacterial count and/or duration of bacterial shedding in the environment, which would provide a 
lower challenge level to both control and treated pigs, one of the principle goals of the application of 
vaccine in populations (Carpenter, 2001). Extrapolation of the beneficial effects of M. 
hyopneumoniae vaccine from the reported trials to modem segregated production s\stems would be
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more appropriate ii the vaccine effect was measured at the cohort level rather than the pen of 
individual pig-level. Further, a study period sufficiently long to include the time of year when 
pneumonia prevalence is expected to be higher and lower would improve the ability to infere effect 
sizes accross season (Maes et al., 1999; Stark et al., 1998). Two recent studies evaluated M. 
hyopneumoniae vaccine effects at the cohort level and found vaccine to have a favorable effect on 
ADG (1.73 and 3.6%) and feed efficiency (3.27 and 2.41%) (Pallares et al., 2000; Maes et al., 1999) 
In these two studies, PRRSv infection was reported present in the cohort but the disease was poorly 
characterized. Recent studies show that M. hyopneumoniae infection potentiates PRRSv lung 
lesions and that M. hyopneumoniae vaccine has a protective effect on PRRSv lesions (Thacker et al.. 
1999; Thacker et al., 2000). In future studies designed to estimate the effect of M. hyopneumoniae 
vaccine in modem age-segregated production systems treatment etfects should be measured at the 
cohort level and should examine possible effects ot PRRSv on M. hyopneumoniae vaccine efficacy.
I able 4.1 Design characteristics and results of studies testing the effect of M. hyopneumoniae 
vaccine in growing pigs.
Reference N 1 Challenge
model
Duration 
(weeks of
Vaccination 
time (weeks
% change compared to control negative
age) of age)
ADG FE PNPR* PNSC* DEAD
Studies using cohorts o f age segregated pigs
Yeske et al , 2000 384 Natural 0 to SLTR4 8 5.6s■’ 9.2s 35.0s
8 and 11 4,1s 9.2s 46.2s
Pommier et al . 2000 12 Natural SLTR 1 and 3 4.8*'' 20s 24.01
Van Nes et al., 2000 24 Natural 0 to SLTR 1 and 3 4.0* 4.1s 14.8“
Pal lares et a l . 2000 16 Natural 8 to 23 1 and 3 1.73* 3.27s 60.7s
Maes et al.. 1999 14 Natural 1 and 3 3.6s 2.41s 48s 65.0s 5 75“
All treatment in same airspace The study unit is the individual pig
I.awton et al.. 2000 8000 Natural 10 to SLTR 1 and 3 7.5* 4.9® 62.2 35.8“
Diekman et al.. 1999 216 Seeder naturally 
infected
0 to 28 1 and 4 2.56“ 0.97“ 23.52“ 0“
Vraa Andersen et al., 1992 1500 Natural 3 to 20 I and 3 0.99s 50.83s 28.0s
3 and 5 4.10s 47.34s 32.45s
Maes et al.. 1998 2060 Natural 11 to 28 1 and 4 4.2s 1.3“
Schwartz et al., 1998 39 Seeder
inoculated Intra 
tracheally
3 and 5 5.69s 5.64s 59.88s 1005 100s
3 and 5 1.90“ 1.33“ 51.68s 67.5s 73.7“
Bilic et al , 1996 140 Natural 10 to 25 12 and 14 12.37 77.44 83.64
Miller and Schueiter, 1998 192 Natural I to 15 3 and 6 9.5s 2.9* 63“
Charlier et al.. 1994 550 Natural 4 to 24 1 and 4 2.10 63.7 40.7
Liuni et al., 1994 312 Natural 3 to 25 2 and 5 0.4“ 74.1s 51.4s
2 and 5 1.4 ns 35.2* 16.13s
Pommier et al., 2000 1287 Natural 10 to SLTR 10 2.22s 3.0“ 9.3* 24.38“ 3.5“
Paterson et al., 2000 1904 Natural SLTR 100% group 
vaccinated
63.5s 45 9s
50% group 
vaccinated
52.8s 12 7“
Munoz et al., 1996 12826 Natural 1 and 3 7.6 3.0 30.0 61.9
Dohoo and Montgomery. 1996 12 Natural 3 and 6
All treatment in same airspace. The study unit is a pen.
Scheldt et al., 1994 18 Seeder naturally 
infected
1 to 26 l and 3 7.69s 6.67** 50.0
6 and 8 7.69s 6.67^ 66.7
Morrow et al . 1994 16 Natural 3 to 21 3 and 5 NS .1 ~-ig— KT*! ..
I and 4 u i .vd
tN: total sample size used to estimate effect o f vaccine on ADG;
of the lung affected by pneumonia
lJNPR: pneumonia prevalence 
F^SC: pneumonia score; proportion 
'SL PR: slaughter
Statistically significant for p < 0.05 
NS: statistically not significant for p < 0.05 
Statistical tests not applied
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5 M Y C O P L A S M A  H Y O P N E U M O N IA E  VACCINE’S PROTECTIVE EFFECT 
MEASURED IN 48 SEGREGATED COHORTS OF FINISHING PIGS 
CONCURRENTLY INFECTED WITH M YC O P LA SM A  H Y O P N E U M O N IA E  AND 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS
5.1 Abstract
The effect of a one dose M. hyopneumoniae vaccine on daily weight gain, feed efficiency, death loss 
rate, substandard pig rate and cull pigs rate was studied in 24 segregated finishing cohorts of pigs 
vaccinated at 9 weeks of age and 24 control negative cohorts of pigs. The study also considered the 
possible interaction between onset of PRRSv infection, measured by seroconversion, and M. 
hyopneumoniae vaccine’s protective effects. M. hyopneumoniae vaccine significantly improved (p < 
0.05) daily weight gain (+ 42 gram per day) and mortality rate (- 1.52%). Feed efficiency, 
substandard and cull pigs rate were not significantly influenced by M. hyopneumoniae vaccination. 
PRRSv infection at the cohort level was described as the average time until PRRSv seroconversion 
(DI PS). Although the median age at which the cohort seroconverted to PRRSv ranged between 29 
and 136 days of age, it was not found to interact with PRRSv ettect; however, it wras found to have a 
main effect on death loss rate and cull rate.
5.2 Introduction
A/, hyopneumoniae infection alone causes a disease ot high morbidity and low mortality resulting 
cough and retarded growth (Straw et al., 1999). M hyopneumoniae infection in conjunction with 
Porcine Reproductive and Respiratory Syndrome virus (PRRSv) is commonly isolated from grovver- 
finisher pigs (Halbur, 1996). Concurrent infection with M. hyopneumoniae and PRRSv has been 
associated with increased macroscopic and microscopic lesions indicative ot PRRSv infection
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(1 hacker et al., 1999). 1 ield studies measuring the effect of M. hyopneumoniae vaccine in the case 
of natural mixed infection are not consistent in their findings (Pallares et al., 2000; Maes et al., 1999; 
Maes et al., 1998). Although these three studies recognized the presence of PRRSv in the herd, the 
onset or severity of PRRSv infection was not described. Variability in the description of the 
protective effects of M. hyopneumoniae vaccine can be caused by the season in which the study was 
carried out (Maes et al., 2000), the agent co-infecting the animals (Ciprian et al., 1994; Amass et al., 
1994), interference with passive antibodies (Jayappa et al.. 2001) or the challenge level challenge of 
M hyopneumoniae (Moore and Daigneault, 2000). Maes observ ed in a cross-sectional study that 
prevalence for M. hyopneumoniae measured on serum from pigs at slaughter is higher in March and 
April as compared to the five other paired months (January-February, May-June etc.) (Maes et al.. 
2000).
Moore measured M. hyopneumoniae vaccine's protective effect on tour treatment groups of twenty- 
tour pigs contact exposed with pigs infected with a high or a low dose ot M. hyopneumoniae (Moore 
and Daigneault, 2000). A protective effect of vaccine was not measurable in low dose challenge but 
was detected in high dose challenge. Vaccine in the high dose challenge study had an etfect on 
severity of lung lesion at slaughter and on the weekly cough index. During mixed infection with 
PRRSv and A/, hyopneumoniae, the role ot PRRSv and M. hyopneumoniae as immunocompromising 
agents are not well defined. Van Alstine found no difference in cough count, peribronchial 
lymphoid hyperplasia and alveolitis among pigs infected with A/. hyopneumoniae or 1 RRSv alone, 
and a co-infection with PRRSv and M. hyopneumoniae (Van Alstine et al., 1996). I hacker (1999) 
reported that M hyopneumoniae potentiates PRRSv pneumonia. In the latter study, microscopic 
lesions representative of PRRSv (interstitial pneumonia) were more severe in cohorts of pigs dually
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infected with M. hyopneumoniae and PRRSv than by M. hyopneumoniae or PRRSv alone. 
Similarly, peribronchiolar lymphoid hyperplasia, lesions consistent with M. hyopneumoniae 
infection, were also more severe in dually infected cohorts of pigs (Thacker et al., 1999). 
Subsequently, 1 hacker demonstrated that M. hyopneumoniae vaccination at 3 and 5 weeks of age 
reduces the macroscopic and microscopic lung lesions indicative of PRRSv observed 38 days after 
experimental challenge with PRRSv and M. hyopneumoniae (Thacker et al., 2000).
The objectives of this study were to describe the course of respiratory disease in pigs reared in a 
commercial farm and estimate the protective effects of a vaccine against M. hyopneumoniae on 
growth performance over an entire calendar year. Specific objectives included the evaluation of M. 
hyopneumoniae vaccination on antibodies to the respirator) pathogens M  hyopneumoniae and 
PRRSv, the measurement of the growth performance parameters daily weight gain (ADG), teed 
efficiency (FE), mortality rate, cull rate and substandard pig rate. Finally, we describe the 
interaction between the time at which a cohort of pigs becomes inlected with PRRSv and the 
vaccine's protective effect.
5.3 Materials and methods
5.3.1 Study population
We selected a farm for study based on the documented occurrence of M hyopneumoniae and the 
ability to replicate adequate numbers of identical farm facilities and consistent pigs for stud} to 
produce a fully blocked study design. The median prevalence ot gross pneumonic lesions among 
180 pigs examined from six cohorts of pigs for the six months immediately prioi to the stud} was 
15.4%. PRRSv, as measured by seroprevalence at slaughter, was present in 0 to 100% ot the pigs 
examined in 6 cohorts of pigs tested pre-study. Based on serological monitoring, the pigs of this
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production system were free ol Actinobacillus pleuropneumonia, pseudorabies virus and influenza 
subtype H3N2.
Two breeding herds supplied all the pigs raised in this production system. The company targeted an 
average weaning age of 18 days and an average weaning weight of 5.4 kg. The standard operating 
procedures allowed for pigs to be weaned as young as 13 days and as old as 21 days. No pigs were 
to be weaned at less than 3.6 kg. At each nursery site, two bams were divided into eight rooms, each 
with 56 pens designed to hold 24 pigs per pen, with 0.217 m allocated per pig. The air is renewed 
by negative pressure mechanical ventilation operated on a timed basis when pigs are between 18 and 
40 days of age, and is later operated on a continuous, temperature-controlled basis. Nursery sites 
were filled within seven days, with pigs segregated into separate rooms by sex. Four nursery rooms 
from each of four nursery sites were enrolled in the study.
At approximately ten weeks of age, each room of pigs was transferred integrally to a single finishing 
barn. Four finishing sites w?ere included in the study, each with eight bams, tour of wiiich were 
enrolled in the studv. Target space allocation was 0.62^ m per pig of floor area, excluding the 
space occupied by the feeders. Barns of females were placed in the middle of the site and barns of 
castrated male were always placed on the extremities of the site (Figure 5.1). Pigs remained in the 
finishing barn for a maximum of 17 weeks.
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figure 5.1 Relative positions ot finishing the eight finishing bams composing one production site, by
the sex of pigs
Castrates Castrates
Females Females
; Females ; : Females
; Castrates } ; Castrates :
Full lines represent bams enrolled in the study 
Doted lines represent barns not enrolled in the study
Finishing barns were 15.24 m x 213.6 m, with concrete slatted flooring over a pit that was drained 
every three to four days to a central lagoon. Each pen had two nipple waterers and one feeder with 
five feeder spaces. Gas heaters and fans thermostatically controlled the environmental temperature 
and air flow. Incoming air entered either through inlets distributed along the ceiling, or through an 
automatically controlled curtain opening at the end of the bam opposite to the fans.
Personnel showered and changed boots and clothes each time they entered a site. In a site, personnel 
moved among pens and between barns as needed to care for the animals without changing clothes or 
boots. Farm personnel could visit a maximum of two sites within a day provided that the first site 
visited raised the youngest animals.
Pigs between 18 and 140 days of age were fed a com/milo/soy based pelleted diet with 12.5% to 
13.5% moisture. Feed for pigs under 63 kg was pelleted, with subsequent rations supplied in meal 
form. The energy density was 700 Mcal/kg. Lysine level for castrated males was 1.12% from 2,-' to 
40 kg. The lysine was successively reduced to 0.89% for 40 to 65 kg pigs. 0.81 % for 65 kg to 85 kg 
Pigs. 0.77% for 85 to 110 kg pigs and lastly to 0.72 % for 110 to 135 kg pigs. The lysine level in
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diets designed for females was approximately 5% higher than diets designed for castrated males. 
Tilmicosin (Pulmotil® -  ELANCO) was added to the feed for pigs between 5.4 and 11 kg at 181 
PPM to help control respiratory diseases. Tylosin (Tylan®- ELANCO) was added to the feed for 
pigs between 11 kg and 40 kg at 44 ppm to help prevent proliferative intestinal enteropathy. 
Bacitracin methylene disalicylate (BMD® - Alpharma) was added to the feed for pigs from 40 kg 
until slaughter at the rate of 30 PPM for growth promotion.
5.3.2 Experimental design
At weaning, forty-eight cohorts of pigs were randomly allocated, to negative control or vaccine 
treatment. The vaccinated groups received one dose of an inactivated M hyopneumoniae vaccine 
intramuscularly at nine weeks of age (Inglevac M hyopneumoniae® one dose, Boehringer 
Ingelheim). Since 16 nursery rooms and finishing bams were available for study, the study was 
broken into three sequential time blocks, using the same facilities for each time block. Four ot eight 
production sites were enrolled into the study. Each production site provided two cohorts of castrated 
male pigs and two cohorts of female pigs. The placement of female and castrated male was 
restricted to castrated males on the south of a site and females on the north of a site. The treatment 
was assigned at random to one of two possible cohorts of pigs of the same sex raised during the
same time block.
In each cohort, blood was collected from 45 randomly selected, individually tagged pigs at
. j„ .,c one From complete sets ol sera, a random 
approximately 30, 55, 80, 105, 135 and 170 days ol age. t
* ■ for antibodies to PRRSv and M. hyopneumoniae.
subset of thirty sera per cohort of pigs was tested tor antmoait
i An «ame testing plate. Sera were tested tor
All samples from a individual were assayed t
60
antibodies against PRRSv with a commercially available enzvme-linked immunofluorescent assay 
(HerdCheck Porcine Reproductive and respiratory Syndrome Virus Antibody Test Kit Ix: IDEXX 
Laboratories, Inc Westbrook ME) following the procedures described by the manufacturer. Samples 
were considered positive to PRRSv if the calculated sample to positive control ratio (S/P) was equal
available enzyme-linked immunofluerescent assay1 (Feld et al., 1992). In accordance with the 
procedure used at two commercial US laboratories (Boehringer Ingelheim Vet Medica and 
University of Illinois), we modified the procedures recommended by the manufacturer. First, the 
substrate ortho-phenylenediamine (OPD) was replaced with the substrate 3,3', 5,5'- 
tetramethylbenzidine (TMB). Second, samples were single tested rather than tested in duplicate. 
Third, the incubation time of 10 minutes was shortened to 7 minutes to reduce the optical density 
value (OD) of the negative control values to the middle of the acceptable range tor quality control. 
Samples were considered positive if the percent inhibition was equal or greater than 0.5 (OD > 
0.200). The OD ratio was calculated as the OD value ot sample OD value ot butter control. To 
allow for a more intuitive interpretation of the OD ratio, the test result was reported as one minus the 
OD ratio.
5.3.3 Biological outcomes considered
Variables compared included average daily weight gain of pigs sold (ADG), feed efficiency (FE). 
death loss rate, the substandard pig2 rate and the cull pigs' rate. All data used to calculate the major 
variables were manipulated using a software custom designed in Structured Query Language (SQL ).
or greater that 0.4. Sera were tested for antibodies against M. hyopneumoniae using a commercially
DAKO Mycoplasma hyopneumoniae ELISA, Glosttup, Denmark
I
pi
Terminology. National Hog Farmer. Page 91 March I, 1999
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1) Substandard pigs
Substandard pigs were identified by one of three methods:
a) Pigs that were transferred to an off site facility to allow further time for growth.
b) Pigs that were visually identified (within the last 30 days prior to the closing of a cohort of 
pigs) as unlikely to meet standard size and so were sold to a market specialized for 
underweight pigs.
c) Pigs that were sold to a market for standard pigs, although their weight was lower than 100 
kg. To count this later category of pigs, each carcass was weighed, and its live weight was 
individually estimated by multiplying the carcass weight by 1.33, the standard multiplication 
factor estimated based on the observation four cohorts of thirty pigs from this farm weighed 
forty-eight hours prior to slaughter and individually tracked through the slaughter line. 
Estimated live weights were then individually corrected to a standard number of days on feed 
(105 days) by either adding or subtracting 0.544 kg/day. the expected growth rate tor this 
farm from 100 to 110 days in the grower-fmisher phase.
2) Cull pigs
Cull pigs, identified by the farm manager as unlikely to reach full market value, were removed from 
the herd 30 days or more prior to slaughter. A single person made the decision to cull or euthanized 
for all study cohorts of pigs, without knowledge ot th e ir  vaccination status
' l ive pig removed from (he herd prior die cohort r e a c h e s  market weighttdueto subsrar j^ rformance Dictionary 
conformation, age or disease. Culling represents a planned effort o controI the o e
Production and Financial Termmotogy. N a t i o n a l  H o g  Farmer. Page 91 March I.
o f
62
3) Mortality
Pigs that died or were euthanized on the farm were classified as mortalities. Pigs were euthanized 
only when the manager expected that they would not survive.
Rates were calculated as the number of dead, cull or substandard pigs, divided by the number of pigs 
entered. Substandard pig rate, cull pigs rate and mortality rate were standardized to the common 
denominator of 1,000 pigs entered into the cohort.
4) Average daily gain
The live weight gain was calculated as the net increase in live weight ot pigs (excluding dead pigs 
from the weight entered), divided by the average number of days on teed (DOF). W eight gained 
was calculated as the difference between the total weight at exit and the total weight at entry7, for
pigs sold.
5) Feed efficiency
The feed efficiency for live pigs was calculated as the total amount of feed used, minus an estimated 
amount of feed eaten by pigs that died, divided by the total live weight gained by standard, 
substandard pigs and cull pigs. The feed consumed by pigs that died was estimated from a growth 
curve for each sex created by the breeding stock supplier and validated internally'. We calculated an 
estimated feed intake of these pigs from the individual date of death, assuming that these pigs ate at
the average level until they died.
1 Mark McCulley, The HANOR Company, Spring Green W1 Personnal Communication
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To assess the time of seroconversion to PRRSv. the median days to PRRSv seroconversion (DTPS) 
was calculated for each cohort of pigs. For each pig, the function of the straight line joining the first 
S/P ratio positive and the last S/P ratio negative was calculated based on the equation Y = Mx + b, 
where Y is equal to the threshold for positive interpretation (SP = 0.4), M is the slope drawxi between 
the SP ratio of the two blood collection, x is the age at the time the SP ratio crosses over the 
threshold for positive interpretation, and b the SP ratio for the last blood collection with a negative 
SP ratio. The date at which Y equaled 0.4 was subtracted from the date of first blood collection. If 
pigs became infected with PRRSv in the farrowing house, the time to PRRSv seroconversion was 
assumed to be nine days of age, which was approximately half of the weaning age. If pigs remained 
negative on all six blood collections, DTPS was assigned the maximum age at the last blood 
collection for that cohort.
I he cumulative incidence for M hyopneumoniae represented the proportion ot pigs developing a 
positive antibody response (> 50 % inhibition). 1 he denominator used tor this cumulative incidence 
was the total number of pigs tested (Thrusfield, 1999).
5-3.4 A priori power analysis
Using an n of 20 vaccinated and 20 non-vaccinated cohorts ot pigs, the power calculation tor the 
conservative unpaired t-test suggests an 80% power to detect a difference in ADG of 0.0j94 
kg/pig/day or approximately 4 .1 kg change per market weight pig. An unpaired t-test reflects the 
minimum power associated with our study design. We expect that applying a more appropriate 
statistica test, will increase the power and ability to detect a significant difference.
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5.3.5 Statistical analysis
The author analyzed the data using analysis of variance with fixed and random effects 
(PR()C MIXED, SAS 6 .12). I he design was viewed as a split-split plot model with sex as the first 
plot level and site the second plot level. We included a random effect for the time of the year when 
the cohort of pigs was studied (time block). Statistical tests for the main treatment was considered 
significant if p < 5% (two sided). The fully specified model was simplified in a stepwise fashion, 
retaining all main fixed effects, but only retaining the interactions of fixed effects with a p-value less 
than 0.05.
To test whether DTPS should be regarded as an effect modifier, we added the variables DTPS and 
DTPS*TREATMENT to the simplified models, using a critical p-value < 0.05. To assess whether 
DTPS should be included in the model as a covariate, we added terms DTPS and DTPS- to the 
simplified models, and retained these variables only it their corresponding p-value was < 0.05. The 
coefficients for TREATMENT were compared with and without DTPS variables. If the changes 
were both greater than 10% and were large enough to be biologically relevant, DI PS was reported 
as potentially confounding the relationship between rREATMENT and the outcome variables .
5.4 Results
I he effect of vaccine for each outcome is reported in separate statistical models (Table 5.1). 
Vaccinated cohorts grew 42g/day faster than controls, corresponding to a 5.2% higher ADG (p -  
0.05). The mean mortality rate was 15.2 p ig s/l.000 pigs lower in vaccinates than in controls.
""chapter 5 in l.ittell RC\ Miliken GA, Strouop WW and Wolfmger RD. SAS System for Mixed Models. 1996. SAS
Institute Inc., Cary, NC, USA.
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corresponding to a 25.0% lower death loss (p = 0.01). We did not detect an effect of vaccination on 
feed efficiency, cull rate nor substandard pig rate.
Table 5.1 The effect of M. hyopneumoniae vaccine on growth performance of pigs
Production
parameters
Vaccinated1 Unvaccinated1 p-value LS difference"
ADGJ 0.811 0.853 0.05 0.042°
FE4 2.786 2.779 0. 88 0.007
Mortality rate5 60.92 45.70 0.006 15.22d
Substandard6 rate5 30.60 31.04 0. 45 0.44
Cull rate5 125.58 112.90 0. 89 12.68
'Twenty-four cohorts o f  approximately 1,200 pigs vaccinated once with lngelvac M. hyopneumoniae vaccine at nine 
weeks of age and Twenty-four cohorts of approximately 1,200 pigs were not vaccinated and used as negative control
2 Least square difference between the mean for vaccinated and unvaccinated cohorts ot pigs 
Average daily weight gain calculated for live pigs from 10 to 26 weeks of age 
4 Feed efficiency, calculated for live pigs 
Rate is the number o f pigs, dead, substandard pigs or cull pigs divided by the total number of pigs placed
0 Substandard pig is a pig sold outside of its target market weight range and/or substantially discounted from the price 
received for other pigs in it contemporary cohorts of pigs 
Cull pig is a live pig removed from the herd due to substandard pigs performance, behavior, confirmation, age, or 
disease.
DTPS did not interact with vaccination nor did it substantially change the size of the treatment eftect 
for any outcome (Table 5.2). However. DTPS had a direct linear association with the mortality rate 
(P = 0.03). A 36 day delay in seroconversion to PRRSv was associated with an increase in mortalit\ 
of 10 pigs per 1,000 pigs entered. DTPS and DTPS' were associated with the cull rate (p0TPS: =
0.05).
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I able 5.2 Growth performances tor cohorts of pigs vaccinated and not vaccinated against M 
h yopn eu m on iae  and the p-value ot the covariate median time until cohort of pigs become positive to 
PRRSv (DTPS).
Variables Un vaccinated1 Vaccinated' p-value
ADG3 0.810 0.854 0.05
FE4 2.789 2.776 0.88
Mortality rate5 61.49 45.13 0.01
Substandard6 rate5 30.07 31.57 0.45
Cull rate5 125.84 112.64 0.89
Twenty-four cohorts o f approximately 1,200 pigs vaccinated once with Ingelvac M hyo vaccine at nine weeks of age 
and twenty-four cohorts o f approximately 1,200 pigs were not vaccinated and used as negative control
2 Least square difference between the mean for vaccinated and unvaccinated cohorts of pigs
Average daily weight gain calculated for live pigs
4 Feed efficiency, calculated for live pigs
Rate was calculated as the number of pigs, dead, substandard pigs or cull pigs divided by the total number o f pigs
placed
h Substandard pig is defined as a pig sold outside of its target market weight range and'or substantially discounter from 
the price received for other pig in it contemporary cohorts of pigs 
Cull pig is defined as a live pig removed from the herd due to substandard pigs performance, behavior, confirmation,
age, or disease.
Table 5.3 Least square difference for growth performances tor cohorts of pigs vaccinated and not 
vaccinated against M. hyopneumoniae with and without the effects of the covariate median time until 
cohort of pigs become positive to PRRSv (DTPS).
Variables LSD'
without covariate with covariate Change (%)
ADG4 0.042d 0.043d ”  2.4
PE5 0.007 0.014
Mortality rate6 15.22d 16.36d 2.2
Substandard rate* 0.44 1 -50
Cull8 rate6_____________________ 1--68___________
'Twenty-four cohorts o f approximately 1,200 pigs vaccinated once with Ingelvac M hyo vaccine at nine weeks o f age. 
'Twenty-four cohorts o f  approximately 1,200 pigs were not vaccinated and used as negative control 
Least square difference between the mean for vaccinated and unvaccinated cohorts ot pigs 
Average daily weight gain calculated for live pigs 
f eed efficiency, calculated for live pigs
6 Rate was calculated as the number o f pigs, dead, substandard pigs or cull pigs divided by the total number o f ptgs 
placed
7s, .u* * , , , * . • . .  * a* market weight ranee and/or substantially discounted fromSubstandard pig is defined as a pig sold outside ot its target market wcigm « *
the price received for other pig in it contemporary cohorts of pigs
* Cull pig is defined as a live pig removed from the herd due to substandard pigs performance, behavior, confirmation,
age, or disease.
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Table 5.4 Statistical significance tests for the potential associations between five measures of pig 
performance and 1) the age at seroconversion to PRRS virus (DTPS) and 2) the potential interaction 
between this time to seroconversion and vaccination against M. hyopneumoniae.
P-value
DTPS' * TREAT* DTPS'
ADG3 0.57 0.46
FE4 0.28 0.18
Mortality rate5 0.09 0.03
Substandard6 rate5 0.56 0.74
Cull rate5 0.97 0.05
1 Days to PRRSv seroconversion, the median age (days) when a cohort of 1.200 pigs seroconvert to PRRSv.
treatment was M. hyopneumoniae vaccine given to twenty-four cohorts of approximately 1,200 pigs vaccinated once 
with Ingelvac M hyo vaccine at nine weeks of age. Twenty-four cohorts of approximately 1,200 pigs were not 
vaccinated and used as negative control
Average daily weight gain calculated for live pigs
4 Feed efficiency, calculated for live pigs
Rates were calculated as the number o f pigs dead, sold to a substandard market or culled, divided by the total number
of pigs placed in the cohort.
"Substandard pig is defined as a pig sold outside of its target market weight range and/or substantially discounted from 
the price received for other pig in it contemporary cohorts of pigs
Cull pig is defined as a live pig removed from the herd due to being severely problems with underweight, behavior,
confirmation, or disease.
Figure 5.2 The predicted upper and lower effect of the age at PRRSv seroconversion (DTPS) on the 
culling rate in a commercial pig production system, based on a statistical model.
o  o o o o o o o o o o o
z  c o ’f r i n c o r ' - c o o o T - c s i c o
Batch average number of days until PRRS 
seroconversion (days of age)
The full and doted lines were estimated from the SAS linear model where castrated males not vaccinated and raised 
during the time block 1 were categorized to estimate highest cull rate (full line) and where females vaccinated and raised 
during the time block 3 were categorized to estimated the lowest cull rate of the pigs under study (doted line)
Change in onset o f seroconversion from 70 days to 50 days was associated with an increase of 8.33 mortality per 1,000 
pigs entered, while a change in onset o f seroconversion from 100 to 120 days was associated with an increase o f 6.51 
deaths per 1,000 pigs entered.
Three weeks following vaccination 33 of 720 vaccinated pigs and 16 ot 720 control pigs had 
detectable antibodies to M. hyopneumoniae. The M. hyopneumoniae cumulative incidence lor 
vaccinated cohorts ranged between 3% and 96.7% while the cumulative incidence tor control 
cohorts ranged between 0% and 100%. The median M. hyopneumoniae cumulative incidence was 
44.00% and 40.7% for vaccinated and control cohorts, respectively. The median M. hyopneumoniae 
cumulative incidence was 88.0%, 10.0% and 11.7% for the first, second and third time blocks. The 
cumulative M. hyopneumoniae incidence was less than 10% in nine cohorts of controls and three 
cohorts vaccinates). For these twelve cohorts, the prevalence of gross lung lesions at slaughter 
ranged between 2 and 78%.
PRRSv antibodies were detected in 77 pigs at weaning, and these individuals had detectable 
antibodies during all five subsequent blood collections. No antibodies against PRRSv were found in
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74 pigs for all six blood collections. The median DTPS for controls and vaccinates was 74.26 and 
75.72 days ot age, respectively. 1 he median DTPS for time blocks one, two and three were 88.69. 
79.29, and 56.25 days of age respectively, with a standard deviations of 15.25, 32.74 and 19.00 days
5.5 Discussion
The 5.2% improvement in rate of gain detected in this study is within the range of findings in other 
experimental and field based reports (chapter 1), and is higher than reported in the two studies most 
similar in design. These studies used naturally infected pigs, had concurrent controls, and 
considered the entire airspace as the unit of analysis (Maes et al., 1999; Pallares et al., 2000).
Pallares reported a non-significant improvement of 1.73% in a study of 16 total cohorts of pigs, 
while Maes reported a 3.6% improvement (p < 0.05), studying eleven pairs of vaccinates and 
controls (Maes et al., 1999).
Prior studies have reported the effects of vaccine only during a portion of the year, including the 
Maes and Pallares reports; in contrast, our study documented the effects of vaccine across all 
seasons. In addition, the current study uniquely documents vaccination ettects for production 
system that has become popular worldwide, the three site, age segregated production system (Harris, 
2000). I he improvements in rate of gain and mortality rate reported in the study have the potential 
for biologically and economically important benefits. The improved rate of gain from vaccination 
would result in an additional five kilograms of weight per pig tor pigs allowed the full 17 week 
finishing stage. Based on 1 200 pigs per finisher bam, a 15.2/1.000 reduction in mortality rate 
would increase the weight of pigs sold by 2,189 kg per cohort, assuming that surviving pigs reach
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the average market weight for this trial (120 kg). In combination, improvements in these two 
parameters could result in an additional 8,189 kg sold per cohort of 1,200 pigs.
Although M. hyopneumoniae infection alone has previously not typically been associated with high 
mortality (Straw, et al., 1999), vaccination against M. hyopneumoniae in this study reduced mortality 
rate by 15.2 pigs per 1,000, or a relative decline of 25.0%. The mechanism by which M  
hyopneumoniae infection could increase mortality is not well defined, since with rare exception 
(Goodwin, 1972), experimental challenge studies have not often reported associations with 
mortality. However, one recent study documented that mortality rate was reduced by 23.8 pigs per
1.000 (Pallares et al., 2000), and second study documented non significant reduction of 2.3 pigs per
1.000 (Maes et al., 1999). This relatively large variation in effect size among studies may be in part 
attributed to differences in concurrent endemic diseases other than M. hyopneumoniae. Our study is 
the only large-scale report using pigs documented to be negative to pseudorabies and Actinobacillus 
pieuropneumoniae, two common respiratory pathogens. In addition to our study, the only other 
study of pigs co-infected with HjNj and H3N2 influenza subtype was Maes (Maes al., 1999).
1 he protective effect of M. hyopneumoniae vaccine on mortality may be through the reduction of M. 
hyopneumoniae, or may be indirect, through effects on onset and severity ot PRRSv infection 
( rhacker et al., 1999). However, this hypothesis has not been supported by other tield-based studies, 
since previous reports have not documented the time to PRRSv infection in. In a study lacking 
concurrent controls, A/, hyopneumoniae vaccine was reported to reduce mortality and cull rate 
(Yeske et al., 2000).
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Our model estimated that a 36-day delay in seroconversion to PRRSv increased the mortality rate by 
approximately 10 per 1,000 pigs placed. Onset of PRRSv seroconversion 20 days prior to 70 days of 
age or 20 days after 100 days of age was associated with an increase in cull rate of approximately 10 
pigs per 1,000 pigs (Figure 5.2). These findings suggest the possibility that in PRRSv positive 
systems, earlier onset of PRRSv infection may be preferable to later onset. How'ever, regardless of 
the time of PRRSv seroconversion in relation to M. hyopneumoniae infection, our results suggest M. 
hyopneumoniae vaccination improves production performance.
It is unclear why vaccination did not reduce substandard pig rate significantly, since it had a 
significant and increasing effect on ADG and in a fixed time marketing system such as this, higher 
ADG should logically cause a decrease in underweight pigs. It can be hypothesized that wiiile 
vaccination reduced the number of dead pigs, the marginal survivors may have been smaller than 
their pen mates and were subsequently marketed as substandard pigs rather than dying.
Based on the pneumonia prevalence at slaughter, the cumulative serologic incidence of M. 
hyopneumoniae and the interval of time between PRRSv and M. hyopneumoniae infection changed 
over time blocks, the course of respiratory disease varied over the three time periods in the current 
study. As compared to time block one, the time at which a cohort of pigs seroconverted to PRRSv 
occurred earlier and the average time to M. hyopneumoniae seroconversion occurred later in time 
blocks two and three. As a result, the interval between PRRSv and M. hyopneumoniae infection was 
longer. Seroconversion to A1. hyopneumoniae occurred later during time blocks two and three, and 
M. hyopneumoniae seroprevalence was lower. In spite of this, the beneficial effects ot vaccine on 
ADG and mortality rate did not differ across time blocks, since no interaction was found between
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time blocks and vaccine effects. This apparent variation in disease challenge level may be a 
reflection of seasonal variation and / or real changes in disease prevalence in the production system. 
The production system elected to implement M. hyopneumoniae vaccination system-wide at the start 
of the study, and it is possible that this vaccination indirectly reduced disease challenge of both 
vaccinated and unvaccinated groups over time. M. hyopneumoniae vaccine may be able to reduce 
the duration of infection, the bacterial count in the environment, a desired effect of vaccination in 
populations (Carpenter, 2001), offering a lowered challenge level to both control and treated pigs.
6 CONCLUSION
Risk factors for mortality and substandard pig rates were identified for the farm production system 
under study using data collected between June, 1996 and December, 2000. A retrospective analysis 
of performance data from 469 cohorts of growing pigs w?as conducted to evaluate the effects of sex, 
year, quarter of the year, and their interactions, on mortality and substandard rates. Substandard rate 
was defined as the proportion of animals that did not reach a desired minimal wreight, set by farm 
management, by slaughter age. Analysis of variance showed that the interaction quarter*year had a 
significant effect (p < 0. 01) on mortality rate, where the mortality rate was higher among cohorts 
placed during quarters three and four, corresponding to growth occurring primarily during the colder 
parts of the year in this climate. The mean mortality rate of female cohorts (44.8 deaths / 1.000 pigs) 
was lower than that of castrated male cohorts (64.2 / 1,000 pigs). Similarly, the interaction 
quarter*year had a significant effect (p < 0.01) on substandard pig rate, which was higher among 
cohorts placed during the colder part of the year (quarter 4). The effect of sex on substandard pig 
rate could not be tested.
The relative effects of the feed antimicrobials tilmicosin and carbadox on mortality and substandard 
pig rate were compared in 12 cohorts ot growing pigs. Six cohorts were given tilmicosin from 5 to
11 kg then tylosin from 11 to 25 kg and six cohorts were given carbadox from 5 to 25 kg body 
weight. The cohorts receiving carbadox were also vaccinated for M hyopneumoniae at six and eight 
weeks of age. The cohorts were paired on their sex and the week weaned. Student T-test 
comparisons showed that the mean mortality rate was not significantly different (p = 0.47) for the 
cohorts receiving tilmicosin (81 / 1,000 pigs) versus carbadox (95 1,000 pigs). However, 
substandard rate was significantly different between the two treatments (p « 0.04), where the mean
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substandard pig rate in tilmicosin cohorts was 127 / 1,000 and was 264 / 1,000 for cohorts given
carbadox.
This analysis provided supportive evidence for the role of respiratory infection, especially infection 
with M. hyopneumoniae, in elevated mortality and substandard pig rates. Other observations also 
supported this association, including serodiagnostics as well as histology, microbiology or virology 
examinations, the combination of which demonstrated the presence of M. hyopneumoniae and 
Porcine Reproductive and Respiratory Syndrome virus in the farm system. Gross observation of 
pneumonic lesions from 78 groups of 30 slaughter pigs revealed a median pneumonia prevalence of 
31,0%. Field necropsy conducted on a subset of 97 dead pigs showed that ulcer wras the most 
frequent lesion found in dead pigs. Feeding pigs between 23 and 41 kg with a decreased proportion 
of fine feed particle size (<578 jam) did not result in lower mortality rate, suggesting that feed 
particle size alone may not have explained these findings.
Additional retrospective analyses provided further supportive evidence ol a possible relationship 
between respiratory diseases and poor pig performance, although data structure prevented 
application of statistical tests. Cohorts of pigs vaccinated tor M. hyopneumoniae tended to ha\e a 
lower mortality rate than did cohorts of pigs not vaccinated. Pigs fed antimicrobials targeting 
respiratory pathogens while in the nursery phase appeared associated to a lower rate ot mortality 
than pigs fed antimicrobials targeting intestinal pathogens. The mean mortality rate tor pigs, placed 
in empty finisher sites (6.85%) was numerically lower than the mean mortality rate of pigs placed on 
sites where 26 weeks old pigs were still present (8.66%).
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The effect ot a one-dose M. hyopneumoniae vaccine on daily weight gain, feed efficiency, death loss 
rate, substandard pig rate and cull pig rate was studied prospectively in 24 segregated finishing 
cohorts of pigs vaccinated at 9 weeks of age, compared with 24 control negative cohorts. This study 
also considered the possible interaction between onset of PRRSV infection, measured by the age at 
seroconversion, and M. hyopneumoniae vaccination. M. hyopneumoniae vaccine significantly 
improved (p < 0.05) daily weight gain, with an increased of 42 grams per pig per day, and mortality 
rate, with a decrease of 15.2 mortalities per 1,000 pigs. Feed efficiency, substandard and cull pig 
rates were not significantly influenced by M hyopneumoniae vaccination. PRRSV infection at the 
cohort level was described as the median time until PRRSV seroconversion (DTPS). Although the 
median age at w?hich the cohort seroconverted to PRRSV ranged between 29 and 1 j6  days of age, 
age at seroconversion to PRRSV was not found to change the protective effect ot M. hyopneumoniae 
vaccination. It w-as, however, found to have a direct effect on both mortality and cull rates.
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APPENDIX B : SAS OUTPUT
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The GLM Procedure
The SAS System
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Pr > I t 1 <. 000 1  
Pr >« IMI <. 000 1  
Pr >= IS I <. 000 1
Tests fo r  Normality
Test —S t a t i s t i c ---- -P Value
S hap iro -W ilk W 0.978241 Pr < w i
Kolmogorov-Smirnov D 0.115955 Pr > D 1
Cramer-von Mises W-Sq 0.110124 Pr > w--Sq 1
Anderson-D ariing A-Sq 0.63067 Pr > A--Sq I
0.2235
0.0139
0.0844
0.0974
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The SAS System
the UNIVARIATE Procedure 
Variable: SQSUBS
Stem Leaf # Boxplot
38 4 1 1
36 1735 4 1
34 8 1 i
32 469 3 1
30 35005 5 1
28 3560233 7 +------- +
26 1004 4 1 I
24 111637 6 1 1
22 146685577777 12 *—+--*
20 5702447999 10 1 1
18 244400005 9 +------- +
16 7700369 7 1
14 855 3 1
12 48
1
2 1
1
6 1 1 1
Multiply Stem.Leaf by 10**-2
Normal P r o b a b i l i ty  P lo t  
0.39+ * ** + *+
* +++
* * * +
* * * +
*** +
★ * *
+ * * ★
.23+ *****
★ * * *
★ * * ★ *
* *++
* *++
+++
+++
0.07++*
+------ +------- +_____+_____ + --------+--------+------- +------- +------- +—
-2 -1  0 +1 +2
The SAS System
The GLM Procedure
Class Level In fo rm ation
Class Levels Values
year 4 1997 1998 1999 2000
quarter 4 1 2  3 4
Number of o b se rv a t io n s  75
++*
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The SAS System 
The GLM Procedure
16
D e p e n d e n t V a r ia b le :  SQSUBS
Sum of 
Source DF Squares Mean Square f
Model 12 0.15974099 0.■01331175
Error 62 0.14977126 0..00241567
Corrected T ota l 74 0.30951226
R-Square Coeff Var Root MSE SQSUBS Mean
0.516106 20.55643 0.049149 0.239095
Source DF Type I I I  SS Mean Square F
year 3 0.05361078 0,.01787026
quarter 3 0.01345840 0..00448613
year*quarter 6 0.08847397 0..01474566
The SAS System 
The GLM Procedure 
Level of Level of
17
year q u a r te r N Mean Std Dev
1997 3 2 0.25079999 0.01409703
1997 4 6 0.24678179 0.03631114
1998 1 5 0.30429346 0.05006859
1998 2 7 0.20016835 0.03035466
1998 3 6 0.29591890 0.05931616
1998 4 7 0.26453509 0.08920791
1999 1 6 0.16673959 0.06031163
1999 2 7 0.25761257 0.04907533
1999 3 6 0.30337745 0.05324045
1999 4 6 0.25369334 0.04655776
2000 1 6 0.20812876 0.01479534
92000 2 6 0.19517061 0.02213868
2000 3 5 0.16679925 0.01491693
D E PE N D E N T V A R I A B L E :  A D G O F  L I V E P I G S
5.51
7.40
1 . 8 6
6 . 1 0
The SAS System 
The Mixed Procedure
Model Information 
proc mixed data~pneumonia c l ;  
class Timeblock s i t e  T rea t  Sex; 
model LV_ADG * SEX TIMEBLOCK TREAT 
/S outp~predDG;
random s i t e  s e x * s i t e  sex*site* tim eb lock ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l i c e *  {Treat Sex TIMEBLOCK)
run;
Proc u n iv a r ia te  normal p lo t  data-predDG;
var resid ;
run;
Proc gplot data-predDG;
Plot resid*pred; 
run;
Pr > F 
<.0001
Pr > F 
0.0003 
0.1462 
<-0001
97
Type 3 Tests of Fixed Effects
Num Den
Effect DF DF F Value Pr > f
SEX 1 3 12.,20 0.0397
TIMEBLOCK 2 14 0.,65 0.5363
TREAT
Least Squares Means
1
Standard
23 4.24 0.0510
Effect TREAT TIMEBLOCK Estimate Error DF
TIMEBLOCK 1 0.8242 0..01797 14
TIMEBLOCK 2 0.8486 0..01797 14
TIMEBLOCK 3 0.8229 0..01797 14
TREAT NOVAC 0.8109 0 .01454 23
TREAT VAC 0.8529 0 .01454 23
The UNIVARIATE Procedure 
Variable: Resid
Moments
The SAS System
Value
45.88
47.24
45.80
55.77
58.66
Pr > | t |  
<. 00 01  
<.0001 
<-0001 
<.0001  
<•0001
N
Mean
Std Deviation 
Skewness 
Uncorrected SS 
Coeff V aria t ion
48
0
0.06697453
-1.8653119
0.2108226
Sum Weights 
Sum Observations 
Variance 
Kurtosis 
Corrected SS 
Std Error Mean
48
0
0.00448559
6.87724095
0.2108226
0.00966694
Basic S t a t i s t i c a l  Measures
Location V a r i a b i l i t y
Mean
Median
0.000000
0.005291
Std Deviation 
Variance
0.06697
0.00449
Mode Range 0
In te rquarti le Range 0. 06277
Tests for Location: Mu0**0
Test - S t a t i s t i c - — p Value---------
Student's t t  0 Pr > 11 f 1.0000
Sign M 4 Pr >= |M| 0.3123
Signed Rank S 69 Pr >- i S | 0.4849
98
Tests for Normality
Test - - S t a t i s t i c ---- -p Value-
Shapiro-Wilk 
Kolraogorov-Smi rnov 
Craraer-von Mises 
Anderson-Darling
W
D
W-Sq
A-Sq
0.866074
0.132798
0.148493
1.023554
Stem Leaf
8 6125 4
6 6680 4
4 01055 5
2 16047 5
0 1112899689 10
-0 9886526 7
-2 85841 5
-4 31 2
-6 6 1 
-8 76 2
-io 3i ;
-12  
-14 
-16 
-18 
-20 
-22 
-24 
-26
-28 5 :
Multiply Stem.Leaf by 10**-2
Pr < W 
Pr > D 
Pr > W-Sq 
> A-Sq
Boxplot 
I
Pr
<0.
0.
0,
0,
* —+—*
Normal P r o b a b i l i ty  P lo t
0.09+ ++* * * *
+****
*  *  *  *
****
******
* * * * *4.
****+++
** + + +
*+ + +
* * +
* + * +
+ + +
++ +
+ +
-0.29+ *
+-— +-— ---- +_-----+_---- +_-----
~2 -1  0 +1 +2
0001
0333
0240
0098
99
The Mixed P ro c ed u re
The SAS System
Model Information
proc mixed data-pneumonia c l ;
class Timeblock s i t e  T rea t  Sex;
mode; LV_ADG -  SEX TIMEBLOCK TREAT XDTPS*TREAT/NOINT outp-predDG; 
random s i t e  s e x * s i t e  sex*site* tim eb lock ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l ic e *  {Treat Sex TIMEBLOCK);
run;
Type 3 Tests of Fixed E ffe c ts
Num Den
Effect DF DF F' Value Pr > F
SEX 1 3 11.08 0.0448
TIMEBLOCK 2 14 0.76 0.4848
TREAT 1 21 0.00 0.9653
XDTPS*TREAT 2 21 0.58 0.5713
Least Squares Means Standard
Effect TREAT TIMEBLOCK Estimate Error DF t Value Pr > | t |
TIMEBLOCK 1 0.8270 0 .01964 14 42.11 <.0001
TIMEBLOCK 2 0.8496 0..01851 14 45.91 <.0001
TIMEBLOCK 3 0.8172 0 .02030 14 40.25 <.0001
TREAT NOVAC 0.8097 0 .01475 21 54.89 <.0001
TREAT VAC 0.8528 0 .01477 21 57.76 <.0001
The SAS System
The Mixed Procedure
Model Inform ation
proc mixed data=pneumonia c l ;
class Timeblock s i t e  T reat Sex;
model LV_ADG = SEX TIMEBLOCK TREAT XDTPS
/S outp*=predDG;
random s i t e  s e x * s i t e  sex * s i te* timeblock;
lsmeans TIMEBLOCK TREAT / p d i f f s l i c e *  {Treat Sex TIMEBLOCK);
run;
Type 3 Tests of Fixed E f fe c ts
Num Den
Effect DF DF F Value Pr > F
SEX 1 3 11.75 0.0416
TIMEBLOCK 2 14 0.82 0.4594
TREAT 1 22 4.41 0.0474
XDTPS 1 22 0.58 0.4552
Least Squares Means Standard
Effect TREAT TIMEBLOCK Estimate Error DF t Value Pr > 1t 1
timeblock 1 0.8290 0. 01905 14 43.51 <.0001
TIMEBLOCK 2 0.8502 0. 01808 14 47.03 <.0001
TIMEBLOCK 3 0.8164 0. 01985 14 41.14 <.0001
TREAT NOVAC 0.8102 0. 01464 22 55.35
<.0001
TREAT VAC 0.8536 0. 01464 22 58.32
<.0001
The SAS System 5
The Mixed Procedure
Model Inform ation
proc mixed data»pneumonia c l ;
class Timeblock s i t e  T rea t  Sex;
model lv_FE = SEX TIMEBLOCK TREAT /S outp=predDG; 
random s i t e  s e x * s i t e  sex*site* tim eblock; 
smeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK);
run;
proc u n iv a r ia t e  normal p lo t  data=predDG;
var re s id ;
run;
proc gp lo t data=predDG;
plot re s id*p red ;
run;
DEPENDENT VARIABLE: FE FOR P IG S  SOLD
Type 3 Tests of Fixed E ffe c ts
Num Den
Effect DF DF F Value Pr > F
SEX 1 3 3.60 0.1539
TIMEBLOCK 2 14 9.09 0.0029
TREAT 1 23 0.02 0,8845
Least Squares Means Standard
Effect TREAT TIMEBLOCK Estimate Error DF t  Value Pr > 1t |
TIMEBLOCK 1 2.7725 0.04942 14 56.10 <.0001
TIMEBLOCK 2 2.9363 0.04942 14 59.41 <.0001
TIMEBLOCK 3 2.6388 0.04942 14 53.39 <.0001
TREAT NOVAC 2..7858 0..03646 23 76..40 <•.0001
TREAT VAC 2..7792 0. 
The SAS
.03646 23 
System
76..22 <•.0001
The UNIVARIATE Procedure 
Variable: Resid
Moments
N
Mean
Std Deviation 
Skewness 
Uncorrected SS 
Coeff V a r ia t io n
48
0
0.13698825 
0.83413678 
0.88199174
Sum Weights 
Sum Observations 
Variance 
Kurtosis 
Corrected SS 
Std Error Mean
48
0
0.01876578
1.71939479
0.88199174
0.01977255
Basic S t a t i s t i c a l  Measures
Location
Mean 0.000000 
Median 0.008295 
Mode
In te r q u a r t i l e  Range
V a r ia b i l i ty  
Std Deviation 
Variance 
Range
0.18141
Tests for  Location: Mu0” 0
0.13699
0.01877
0.73667
Test - S t a t i s t i c -  ------- P Value
Student's  t t 0 Pr > 111 1.0000
Sign M 1 Pr >- IMI 0.8854
Signed Rank S -57 Pr >- ISI 0.5643
101
Tests fo r  N o rm a l i ty
Test
Shapiro-Wilk 
Kolmogorov-Smi rnov 
Cramer-von Mises 
Anderson-Darling
—S t a t i s t i c ----
W 0.954402 
D 0.111752 
W-Sq 0.089142 
A-Sq 0.596598
------- p Value---------
Pr < W 0.0600
Pr > D 0.1366 
Pr > W-Sq 0.1555 
Pr > A-Sq 0.1175
Stem Leaf 
4 6 1
4
3
3 0 1
1
2 3 1
1 679 3
1 2 1 
0 55667788889 11 
0 1122333 7 
-0 42 2 
-0 99887765 8 
-1 333221110 9 
-1 96 2 
-2  2 1 
-2  8 1
Multiply Stem.Leaf by 10**-1
Boxplot
I
I
+----- +
*—+—*
I I
Normal P r o b a b i l i ty  P lo t  
0.475+
.325+ * ++++
+++
+ *++
.175+ +***
+++*
+ ***** *
.025+ *****
+ * *
+*****
0.125+ ********
* *+++
*++ +
-0.275+ *++ +
+----+-----+___ +___ +___ +___ +-----+-----+-----+-----+
-2 -1  0 +1 +2
The SAS System 
The Mixed Procedure
Model Inform ation
proc mixed data-pneumonia c l ;
class Timeblock s i t e  T rea t  Sex;
model lv_FE -  SEX TIMEBLOCK TREAT XDTPS*TREAT/N0INT outp-predDG; 
random s i t e  s e x * s i t e  sex*site* tim eb lock ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK);
run;
m o
Type 3 Tests of Fixed Effects
Num Den
Effect DF DF F Value Pr > F
SEX 1 3 4.14 0. 1349
TIMEBLOCK 2 14 6.97 0. 0079
TREAT 1 21 0.71 0. 4085
XDTPS*TREAT 2 21 1.34 0. 2839
Least Squares Means Standard
Effect TREAT TIMEBLOCK Estimate Error DF t  Value Pr > | t |
TIMEBLOCK 1 2.7559 0.05330 14 51.70 <.0001
TIMEBLOCK 2 2.9306 0.05044 14 58.11 <.0001
TIMEBLOCK 3 2.6664 0.05512 14 48.38 <•0001
TREAT NOVAC 2.7906 0.03784 21 73.75 <.0001
TREAT VAC 2.7780 0.03787 21 73.35 <-0001
The SAS System 
The Mixed Procedure
Model Inform ation
proc mixed data-pneumonia c l ;
class Timeblock s i t e  T rea t  Sex;
model LV_FE = SEX TIMEBLOCK TREAT XDTPS
/S outp=predDG;
random s i t e  s e x * s i t e  sex*site* tim eb lock ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l ic e =  (Treat Sex TIMEBLOCK);
run;
Type 3 Tests of Fixed E ffe c ts
Num Den
Effect DF DF F Value Pr > F
SEX 1 3 4.15 0.1344
TIMEBLOCK 2 14 6.91 0.0082
TREAT 1 22 0.09 0.7624
XDTPS 1 22 1.88 0.1839
Least Squares Means Standard
Effect TREAT TIMEBLOCK Estimate Error DF t  Value Pr > i t l
TIMEBLOCK 1 2.7483 0.05407 14 50.83 <.0001
TIMEBLOCK 2 2.9283 0.05143 14 56.94 <.0001
TIMEBLOCK 3 2.6709 0.05622 14 47.51 <.0001
TREAT NOVAC 2.7894 0.03948 22 70.65 <.0001
TREAT VAC 2.7756 0.03948 22 70.30 <.0001
DEPENDENT VARIABLE: MORTALITY
(DEAD PIG /  1,000 PIGS PLACED)
The SAS System 
The Mixed Procedure
Model Inform ation 
proc mixed data-pneumonia c l ;  
class Timeblock s i t e  T rea t  Sex; 
model ADEAD -  SEX TIMEBLOCK TREAT
/S outp-predDG;
random s i t e  s e x ’ s i t e  sex*site* tim eb lock ;
ismean:. TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK);
run;
proc u n iv a r ia te  normal p lo t  data-predDG;
v*r resid ;
run;
Proc gplot data-predDG;
Plot resid*pred; 
run;
Type 3 Tests of Fixed Effects
Num 
Effect 
SEX
TIMEBLOCK
TREAT
Den
DF
1
2
DF
3
14
23
Least Squares Means S tandard
Effect TREAT
TIMEBLOCK
TIMEBLOCK
TIMEBLOCK
TREAT
TREAT
The SAS System
TIMEBLOCK
1
2
3
NOVAC
VAC
The UNIVARIATE Procedure 
Variable: Resid
F Value 
14.96 
2.78 
9.29
Estimate
59.7425
45.5044
54.6794
60.9188
45.6987
Pr > F 
0.0306 
0.0959 
0.0057
Error
5.2315
5.2315
5.2315
4.5971
4.5971
10
DF t  Value Pr
14 11.42 <
14 8.70 <
14 10.45 <
23 13.25 <
23 9.94 <
Moments
N
Mean
Std Deviation 
Skewness 
Uncorrected SS 
Coeff V ar ia t ion
48
0
15.8628761 
0.19570891 
11826.6494
Sum Weights 
Sum Observations 
Variance 
Kurtosis 
Corrected SS 
Std Error Mean
48
0
251.630838
1.9655801
11826.6494
2.28960895
Basic S t a t i s t i c a l  Measures 
Location
Mean 0.000000 
Median 2.634872 
Mode
In te rq u a r t i le  Range
V a r ia b i l i ty
Std Deviation 
Variance 
Range 
16.21348
15.86288
251.63084
91.54780
Tests for Location : Mu0»0 
- S t a t i s t i c -
Student's t  
Sign
Signed Rank 25
-p Value-
Pr > | t |  
Pr >= |MI 
Pr >= |SI
1.0000
0.3123
0.8007
Tests for Normality 
Test
Shapiro-Wilk 
Kolmogorov-Smi rnov 
Cramer-von Mises 
Anderson-Darling
—S t a t i s t i c ----
w
D
W-Sq
A-Sq
0.955557 
0.105179 
0.128857 
0.728519
Pr
Pr
Pr
Pr
-p Value-
< w
> D
> W-Sq
> A-Sq
0.0668
>0.1500
0.0452
0.0547
> l t |  
.0001 
.0001 
.0001  
.0001 
.0001
1 A A
Stem Leaf
014
58
1 034 
0 
0
3
2
3
11
8
56666677789 
11233344
-0 4331 4
-0 8755 4
-1 3210 4
-1 995 3
-2 44 2
-2 8 1
-3 1 1
-3 9 1
Multiply Stem. Leaf by 10**+1
Boxplot
+------+
♦—+—♦
Normal P ro b a b i l i ty  P lo t  
52.5+
* * * * +
»++
++* 
++++■* 
-37.5++++*
-----*___+
-2
+++* 
++ + ** 
+++***
*1
The Mixed Procedure 
Model Information
+ 1 +2
The SAS System
Proc mixed data-pneumonia c l ;
-iass Timeblock s i t e  T rea t  Sex;
r'0de 1 ADEAD -  SEX TIMEBLOCK TREAT XDTPS*TREAT/NOINT outp-predDG;
rr“--iom s i t e  s e x * s i t e  sex*s ite* tim eb lock ;
ismeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK);
run;
The Mixed Procedure
Typ« 3 Tests of Fixed E f fe c ts
Num Den
Effect 
SEX
TIMEBLOCK
TREAT
xdtps*treat
DF DF F Value Pr > F
1 3 25.66 0.0149
2 14 3.25 0.0691
1 21 0.34 0.5646
2 21 2.78 0.0850
105
Least Squares Means S tandard
Effect TREAT TIMEBLOCK Estimate Error DF t  Value Pr > | t |
TIMEBLOCK 1 56.1880 4.9969 14 11.24 <.0001
TIMEBLOCK 2 44.3337 4.6997 14 9.43 <.0001
TIMEBLOCK 3 59.7106 5.1750 14 11.54 <.0001
TREAT NOVAC 61.5744 3.9480 21 15.60 <.0001
TREAT VAC 45.2472 3.9516 21 11.45 <.0001
The SAS System 
The Mixed Procedure
Model Information
proc mixed data-pneumonia c l ;  
class Timeblock s i t e  T re a t  Sex; 
model ADEAD -  SEX TIMEBLOCK TREAT XDTPS 
/S outp-predDG;
random s i t e  s e x * s i t e  s ex * s i te* t im eb lo ck ;
Ismeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK);
run;
The Mixed Procedure
Type 3 Tests of Fixed E f f e c t s
Num Den
Effect DF DF F Value Pr■ > F
SEX 1 3 25.42 0. 0150
TIMEBLOCK 2 14 3.33 0. 0658
TREAT 1 22 10.82 0. 0033
XDTPS 1 22 5.30 0. 0312
Least Squares Means S tandard
Effect TREAT TIMEBLOCK Estimate Error DF t  Value Pr > Itl
TIMEBLOCK 1 55.8877 4.9339 14 11.33 <.0001
TIMEBLOCK 2 44.2469 4.6729 14 9.47 <.0001
TIMEBLOCK 3 59.7917 5.1450 14 11.62 <.0001
TREAT NOVAC 61.4883 3.9338 22 15.63 <.0001
TREAT VAC 45.1292 3.9338 22 11.47 <.0001
D EPEN D EN T V A R I A B L E :  S u b s t a n d a r d  r a t e
(substandard PIG /  1,000 PIGS PLACED)
The SAS System 
The Mixed Procedure
Model Information 
proc mixed data-pneumonia c l ;  
class Timeblock s i t e  T rea t  Sex; 
model ASUBS- SEX TIMEBLOCK TREAT
/S o u t p - p r e d D G ;
random s i t e  s e x * s i t e  sex* s i te* t im eb lo ck ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK);
run;
Proc u n iv a r ia te  normal p lo t  data-predDG;
v*r resid ;
run;
Proc gplot data-predDG;
Plot resid*pred ; 
run;
1 0 6
Type 3 T e s ts  of Fixed  Effects
Hum Den 
Effect DF DF F Value Pr > F
SEX 1 3 0.73 0.4553
TIMEBLOCK 2 14 4.80 0.0258
TREAT 1 23 0.59 0.4501
Least Squares Means S tandard
Effect TREAT TIMEBLOCK Estimate Error DF t  Value Pr > | t lTIMEBLOCK 1 155.13 14.2890 14 10.86 <•0001TIMEBLOCK 2 97.5344 14.2890 14 6.83 <.0001
TIMEBLOCK 3 105.05 14.2890 14 7.35 <.0001
TREAT NOVAC 125.58 11.6669 23 10.76 <■0001
TREAT VAC 112.90 11.6669 23 9.68 <.0001
The SAS System 14
The UNIVARIATE Procedure 
Variable: Resid
Moments
N
Mean
Std Deviation 
Skewness 
Uncorrected SS 
Coeff V ar ia t ion
48
0
54.6696762
1.04606537
140472.354
Sum Weights 
Sum Observations 
Variance 
K urtosis  
C orrected  SS 
Std Error Mean
48
0
2988.7735
4.33900018
140472.354
7.89088807
Basic S t a t i s t i c a l  Measures
Location V a r i a b i l i t y
54.66968 
2989 
346.66000
Mean 0.00000
Median -1.92083 
Mode
In te rq u a r t i le  Range
Std D eviation
Variance
Range
47.22500
Tests for Location : MuO-O 
Test - S t a t i s t i c - — p Value---------
Student’s t t  0 Pr > I t l 1.0000
Sign M -2 Pr >- 1 Ml 0.6655
Signed Rank S -42 Pr >- 1 SI 0.6713
107
Tests fo r  N orm ali ty
Test — S t a t i s t i c ---- -p Value-
Shapiro-Wilk 
Kolmogorov-Smirnov 
Cramer-von Mises 
Anderson-Darling
Stem Leaf 
20 4 
18 
16 
14 
12 
10
8 670
W
D
W-Sq
A-Sq
0.919622 
0.143988 
0.174167 
1.001417
Pr
Pr
Pr
Pr
c W
> D
> W-Sq
> A-Sq
Boxplot
0.0029
0.0140
0.0110
0.0116
4 4489 4
2 0150 4
0 3445025556 10
-0 976229764311 12
-2 62084 5
-4 88871 5
-6 65 2
-8 6 1 
-10
-12 3 ]
Multiply Stem.Leaf by 10**+1
+—+—+
* __________*
+----- +
Normal P ro b a b i l i ty  P lo t  
2 10+
++++
+++
* + * + *
++++
++****
+++***
.******
***++
•* *  *  *
* *+++
*+++
+++
-130++++*
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The SAS System
The Mixed Procedure
Model Information
P^oc mixed data-pneumonia c l ;  
cl*ss Timeblock s i t e  T rea t  Sex;
model ASUBS* SEX TIMEBLOCK TREAT XDTPS*TREAT/NOINT outp-predDG; 
^ndom s i t e  s e x * s i t e  se x * s i te * t im e b lo c k ;
smeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK);
run;
108
Type 3 Tests of Fixed E f f e c t s
Num Den 
Effect DF DF F Value
SEX 1 3 0.72
timeblock 2 14 3. 66
treat 1 21 1.56
XDTPS*TREAT 2 21 0.61
Least Squares Means S tandard
Effect TREAT timeblock Estim ate
timeblock 1 151.30
timeblock 2 96.3612
timeblock 3 108.00
treat NOVAC 125.27
treat VAC 111.84
Pr > F
0.4580
0.0528
0.2257
0.5547
Error DF t  Value Pr > | t !
15.4330 14 9.80 <.0001
14.5296 14 6.63 <.0001
15.9547 14 6.77 <.0001
11.8122 21 10.60 <.0001
11.8244 21 9.46 <.0001
The SAS System 
The Mixed Procedure
Model Information
proc mixed data-pneumonia c l ;
class Timeblock s i t e  T rea t  Sex;
model ASUBS = SEX TIMEBLOCK TREAT XDTPS
/S outp-predDG;
random s i t e  s e x * s i t e  s ex * s i te* t im eb lo ck ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l i c e =  (Treat Sex TIMEBLOCK);
run;
Type 3 Tests of Fixed E f f e c t s
Num Den
Effect DF DF F Value Pr > F
SEX 1 3 0.67 0.4731
TIMEBLOCK 2 14 3.92 0.0445
TREAT 1 22 0.62 0.4389
XDTPS 1 22 0.12 0.7351
Least Squares Means S tandard  
Effect TREAT TIMEBLOCK
TIMEBLOCK
TIMEBLOCK
TIMEBLOCK
TREAT
TREAT
1
2
3
NOVAC
VAC
Estimate Error DF t  Value Pr > I t |
153.37 15.3231 14 10.01 <.0001
96.9607 14.5347 14 6.67 <.0001
107.39 15.9620 14 6.73 <.0001
125.84 11.8129 22 10,65 <.0001
112.64 11.8129 22 9.54 <.0001
D E PEN D EN T V A R I A B L E :  C u l l  p i g s  r a t ®
(cull pigs / 1,000 p ig s  p laced)
The SAS System
The Mixed Procedure
Model Information
Proc mixed data-pneumonia c l ;
class Timeblock s i t e  T re a t  Sex;
model ACULL- SEX TIMEBLOCK TREAT
/S o u t p - p r e d D G ;
Random s i t e  s e x * s i t e  s e x * s i te * t im e b lo c k ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK),
run;
proc u n iva r ia te  normal p l o t  data-predDG;
v«r reaid;
run;
proc gplot data-predDG; 
plot resid*pred; run;
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Type 3 Tests
Num Den
Effect
SEX
timeblock
t r e a t
Fixed
DF
E f f e c t s  
DF F Value Pr > F
1 3 0.69 0.4677
2 14 0.93 0.4170
1 23 0.02 0.8923
Least Squares Means S tandard
Effect TREAT TIM EBLO CK  
TIMEBLOCK 1 
TIMEBLOCK 2 
TIMEBLOCK 3 
TREAT NOVAC
TREAT
The SAS System
VAC
Estim ate Error DF t  Value Pr > | t |
33.6812 6.9156 14 4.87 0.0002
34.6094 6.9156 14 5.00 0.0002
24.1694 6.9156 14 3.49 0.0036
31.0421 5.1545 23 6.02 <.0001
30.5979 5.1545 23 5.94 <-0001
18
The UNIVARIATE Procedure 
Variable: Resid
Moments
N
Mean
Std Deviation 
Skewness 
Uncorrected SS 
Coeff V ariation
48
0
8.53252349
1.283741
3421.78599
Sum Weights 
Sum Observations 
Variance 
K urtosis  
Correc ted  SS 
Std Error Mean
48
0
72.8039571
4.0274891
3421.78599
1.23156368
Basic S t a t i s t i c a l  Measures
Location
Mean 0.00000
V a r i a b i l i t y
Std D ev ia tion 8.53252
Median -1.09443 V ariance 72
Mode Range 49
In terquartile  Range 6. 64921
Tests for Location: MuO-O
Test - S t a t i s t i c -
Student's t  t 0 Pr > I t l  1..0000
Sign M -5 Pr >» |M| 0., 1934
Signed Rank S -64 Pr >- 1SI 0 ..5173
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Tests fo r  N orm ali ty
Test —S t a t i s t i c ---- -p Value-
Shapiro-Wilk 
Kolmogorov-Srai rnov 
Cramer-von Mises 
Anderson-Darling
w
D
W-Sq
A-Sq
Stem Leaf
0 . 9 1 7 2 8 4
0 . 1 6 1 7 6 8
0 . 1 7 3 9 6 9
0 . 9 5 1 2 0 3
3 3 1
2
2
1 7 1
1 0223 4
0 56677 5
0 11222222  8 
-0 44433332111111100 17
-0 9887555 7
-1 210 3
-1 65 2
Multiply Stem. Leaf by 10**+1
Fr
Pr
Pr
Pr
w
D
W-Sq
A-Sq
0 . 0 0 2 4
<0 . 0 10 0
0.0111
0 . 0 1 6 3
Boxplot
Normal P ro b a b i l i ty  P lo t  
32.5+
.5+
*+++++
***+*+
++****
+++<**********
*+*+*++ 
-17.5+ +*++++
+-----+------+_---- h
- 2  - 1 + 1 +2
The SAS System
The Mixed Procedure
Model Information
proc mixed data-pneumonia c l ;  
class Timeblock s i t e  T re a t  Sex;
model ACULL- SEX TIMEBLOCK TREAT XDTPS*TREAT/NOINT outp-predDG; 
random s i t e  s e x * s i t e  se x * s i te * t im e b lo c k ;
lsmeans TIMEBLOCK TREAT / p d i f f  s l i c e -  (Treat Sex TIMEBLOCK); 
run;
Type 3 Tests of Fixed E f f e c t s
Num Den 
Effect 
SEX
TIMEBLOCK 
TREAT
XDTPS*TREAT
DF DF F V a l u e Pr > F
1 3 0 . 6 6 0 . 4 7 5 5
2 14 0 . 7 2 0 . 5 0 5 7
1 21 0 . 0 7 0 . 7 8 9 4
2 21 0 . 0 3 0 . 9 7 0 6
Least Squares Means S tandard  „ , A Dr
Effect TREAT TIMEBLOCK Estim ate  Error DF t Value
TIMEBLOCK !  3 3 . 6 0 1 6  7 . 3 5 8 6  14 4 . 5 7  0
TIMEBLOCK 2 34 5 8 7 1  7 . 1 0 0 1  14 4 . 8>  0
TIMEBLOCK 3 2 U 7 1 3  7 . 5 4 0 8  14 3 21 0
I ^ AT NOVAC 3 1 . 0 1 1 2  5 . 3 2 9 6  21 5 . 8
TREAT VAC 3 0 . 5 6 2 1  5 . 3 3 1 9  21 5 . 7 3
> I t l  
. 0004  
.0002  
. 0064  
.0001  
.0001
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The SAS System 
The Mixed Procedure
Model Information
proc mixed data-pneumonia c l ;  
class Timeblock s i t e  T re a t  Sex;
model ACULL -SEX TIMEBLOCK TREAT XDTPS XDTPS*XDTPS
/S outp-predDG;
random s i t e  s e x * s i te  s e x * s i te * t im e b lo c k ;
Ismeans TIMEBLOCK TREAT / p d i f f  s l i c e — ( T r e a t  S e x  TIMEBLOCK)* 
run;
Type 3 Tests of Fixed E f f e c t s
Num Den
Effect DF DF F V a l u e Pr > F
SEX 1 3 0 . 6 0 0 . 4 9 6 6
TIMEBLOCK 2 14 1 . 7 6 0 . 2 0 7 2
TREAT 1 21 0 . 2 0 0 . 6 6 3 0
XDTPS 1 21 4 . 4 0 0 . 0 4 8 2
XDTPS*XDTPS 1 21 4 . 5 5 0 . 0 4 4 8
Least Squares Means S tandard  
Effect TREAT
TIMEBLOCK
TIMEBLOCK
TIMEBLOCK
TREAT
TREAT
Effect
Intercept
SEX
SEX
TIMEBLOCK
TIMEBLOCK
timeblock
treat
treat
XDTPS
XDTPS*XDTPS
TREAT
NOVAC
VAC
TIMEBLOCK E s t i m a t e E r r o r DF t  Va l ue Pr :> I t l
1 3 8 . 6 1 8 2 7 . 2 3 6 2 14 5 . 3 4 0 .0001
2 3 3 . 1 3 9 5 6 . 6 8 3 7 14 4 . 9 6 0 .0002
3 2 0 . 7 0 2 2 7 . 2 3 2 2 14 2 . 8 6 0.. 0125NOVAC 3 0 . 0 7 2 5 5 . 0 1 9 4 21 5 . 9 9 < .0001
VAC 3 1 . 5 6 7 5 5 . 0 1 9 4 21 6 . 2 9 <,.0001
)f f e c t s
SEX TIMEBLOCK E s t i m a t e Er ror DF t Value
6 9 . 9 1 6 5 2 5 . 1 7 7 6 3 2 . 7 8
B 5 . 0 7 2 5 6 . 5 7 4 9 3 0 . 7 7
G 0
1 1 7 . 9 1 6 0 9 . 8 8 2 3 14 1 . 81
2 1 2 . 4 3 7 3 8 . 6 3 6 5 14 1 .44
3 0 .
- 1 . 4 9 5 1
n
3 . 3 8 2 2 21 - 0 . 4 4
U
- 1 . 3 0 7 3 0 . 6 2 3 0 21 - 2 . 1 0
0 . 0 0 7 4 2 2 0 . 0 0 3 4 7 9 21 2 . 1 3
